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Full Thesis Abstract 
Background: Chronic pain conditions particularly fibromyalgia (FM) are an important 
issue considering the demand that they place on health services and the negative impact 
on an individual’s well-being. Research regarding what impact FM may have on the 
various domains of health related quality of life is sparse. In addition, research identifying 
predictors relating to a person’s self-concept on pain outcomes such as quality of life and 
disability is scarce in a chronic pain population. Self-esteem has been linked to 
psychological adjustment in various chronic diseases (Chong et al, 2009) and is suspected 
to be a vulnerability factor in FM (Johnson et al., 1997; Michielsen et al., 2006). Research 
on self-compassion found that it is a significant predictor of increased psychological 
adjustment in people with chronic medical conditions (Wren, Somers, & Wright, 2011). 
The majority of research on self-compassion has been conducted in non-clinical samples. 
Identifying the predictive values of self-esteem and the self-compassion subscales (self-
warmth and self-coldness) in relation to pain outcomes are useful provided they can be 
enhanced and utilised to inform intervention. 
Aims: This research portfolio had two aims, to systematically review and carry out a 
meta-analysis with the literature investigating the impact of FM on health related quality 
of life using the Short Form-36 version one and to investigate whether self-warmth, self-
coldness and self-esteem act as predictors of quality of life and disability for individuals 
with chronic pain. 
Method: A systematic review and meta-analysis of studies which assessed the impact of 
FM on health related quality of life was undertaken. Sensitivity and subgroup analyses 
were conducted to address the level of heterogeneity in the studies. The empirical study 
comprised of a cross-sectional design in which 60 individuals with chronic pain were 
recruited from three NHS sites based in Fife and Lothian and a pain self-management 
group in Fife to complete six validated psychometric questionnaires: Self Compassion 
Scale (Neff, 2003), Rosenberg Self-Esteem Scale (Rosenberg, 1965), Brief Pain Inventory-
Short Form (Cleeland, 1991), Pain Disability Questionnaire (Anagnostis, Gatchel, & 
Mayer, 2004), Hospital Anxiety and Depression Scale (Zigmond and Snaith, 1983) and 




Systematic Review Results: In total, 18 studies met the inclusion criteria of the systematic 
review and demonstrated that the health related quality of life of individuals with FM 
was lower compared to healthy controls on all eight subdomains of the SF-36 particularly 
Physical Role. It was found that Social Functioning was the subdomain least affected 
when comparing participants with FM to healthy controls. 
Empirical Project Results: Quality of life was lower than previous research with females 
reporting a higher level of quality of life than males. It was found that after controlling 
for demographic and clinical variables, self-warmth was the only significant predictor for 
quality of life but not on levels of disability.  Neither self-coldness nor self-esteem were 
significant predictors on scores of quality of life or disability. 
Conclusion: The above studies expand literature on the nature of chronic pain and its 
outcomes such as health related quality of life. The meta-analysis evidenced that HRQoL 
was lower in individuals with FM than in healthy controls. The association between 
symptom severity and quality of life requires further investigation in FM.  
Psychological interventions targeting the development of self-warmth attributes and 
skills may have a beneficial effect in improving quality of life for people with chronic pain. 
While the systematic review highlighted that FM has a more significant impact physically 
rather than mentally in relation to quality of life, both studies highlighted the need for 










Lay Summary of Thesis 
This thesis consists of two papers. The first paper looks at the effect that fibromyalgia has 
on people’s quality of life. Fibromyalgia is a long term condition that causes pain all over 
the body. Quality of life was measured by a questionnaire called the Short-Form-36. This 
questionnaire focuses on eight different areas of quality of life known as subdomains 
regarding ability to carrying out physical activities, general health, pain, mental well-
being, ability to interact socially, and energy levels. The first paper looked at 18 studies 
which compared the scores of the SF-36 subdomains for people with fibromyalgia to 
people who do not have any pain conditions. People who do not have any pain condition 
are referred to as healthy controls in the present study. This study combined all scores of 
the 18 studies for the SF-36 subdomains together to get an average score in order to see 
which one would be most affected in people with fibromyalgia compared to healthy 
controls. It was found that people with fibromyalgia reported poorer quality of life than 
healthy controls particularly in relation to their physical ability to carry out activities. 
Ability to interact socially was least affected in people with fibromyalgia compared to 
healthy controls.  Overall it was concluded that people with fibromyalgia are not all 
similar with regards to levels of quality of life and reasons for this should be explored 
further in future research. The second paper in this thesis focuses on people with chronic 
pain, which means that they have had continuous pain for at least three months. This 
paper aimed to answer whether an individual’s sense of worth (self-esteem) or an ability 
to be kind to oneself (self-warmth) or judgemental to oneself (self-coldness) in times of 
difficulty predicted pain outcomes in relation to their levels of quality of life and level of 
disability. Sixty Individuals with chronic pain completed six questionnaires which asked 
questions relating to their severity of pain, mood, quality of life, disability, self-esteem, 
self-warmth and self-coldness. It was found after carrying out statistical analysis that 
people with higher levels of self-warmth regardless of mood or pain had better levels of 
quality of life but it did not affect levels of disability. However, self-coldness and self-
esteem did not predict better or poorer levels of quality of life or disability. From the 
results of this study, it was suggested that psychological interventions should be aimed 
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Objective: To systematically review the literature to identify the impact of fibromyalgia (FM) 
on individuals with fibromyalgia in comparison to aged matched healthy controls on specific 
aspects of health related quality of life (HRQoL) using the Medical Outcomes Study Short-
Form-36 (SF-36). 
Methods: Multiple electronic databases were searched for studies reporting SF-36 
subdomain mean and standard deviation scores for people with FM and healthy controls. 
Studies were methodologically appraised using a specifically developed quality criteria tool. 
A random-effects meta-analysis was performed to address the review questions. 
Results: In total, 18 studies were eligible for inclusion in the meta-analysis, reporting on 1733 
individuals with FM and 3468 healthy controls. Meta-analyses found that the subdomain 
Physical Role was the most severely effected in individuals with FM compared with Healthy 
Controls. The least affected subdomain was found to be Social Functioning (SF). It was 
calculated that the meta-analysed pooled mean HRQol score for the SF-36 physical 
component summary score was 38.81 (95% CI: 31.2-46.4) and mental component summary 
score was 42.3 (95% CI: 34.3-50.2). Sensitivity analyses in relation to the methodology quality 
criteria did not significantly reduce heterogeneity in the review. Subgroup analysis did find a 
reduction in heterogeneity in relation to geographical area. 
Conclusions: Individuals with FM have lower levels of HRQoL than healthy controls. This 
review supports that FM seems to have a greater negative impact on physical rather than on 












Fibromyalgia (FM) is a chronic pain disorder that affects 2-3% of the general population 
and is more prevalent in middle aged women (Quieroz, 2013). The prevalence of 
fibromyalgia can vary depending on different countries (Branco, Bannwart, Failde et al., 
2010). Similarly, the particular characteristics and symptoms reported by individuals with 
fibromyalgia may differ depending on geographical regions which has been found among 
patients with chronic widespread musculoskeletal pain (McBeth & Jones, 2006). The 
American College of Rheumatology (ACR; 1990) developed criteria to classify FM for 
research, which included the presence of chronic widespread pain in combination with 
tenderness on examination at 11 or more 18 anatomical sites known as tender points. In 
2010, the ACR introduced new preliminary diagnostic criteria which no longer requires 
tender point examination. Although FM is characterised by widespread pain, other 
symptoms include fatigue, sleep disturbance, morning stiffness, headaches and 
depressive mood (Wolfe, Clauw & Fitzcharles, 2010). The aetiology of FM is unknown, 
although it is generally considered a central sensitization syndrome (Clauw, 2014). This 
refers to the theory that the central nervous system may amplify sensory input across 
various organ systems resulting in a heightened sense of pain in a number of areas e.g. 
headaches, irritable bowels, tender points (Woolf, 2010). There is no known cure for FM, 
therefore, treatment is focused on preserving or improving daily function and alleviating 
pain (Albin, Fitzcharles, & Buskila, 2013).  
FM has diverse effects on health-related quality of life (HRQoL), both physically and 
mentally (Hoffman & Dukes, 2008). Various terms have been used interchangeably with 
HRQoL including functional status, health status, and quality of life (Van Son, De Vries, 
Roukema, & Den Oudsten, 2013). An international group of researchers suggest that 
there are six fundamental domains of HRQOL: physical functioning, psychological 
functioning, social functioning, role activities, overall life satisfaction and perceptions of 
health status (Berzon, Hays, & Schumaker, 1993). While the objective dimensions aim to 
define a patient’s degree of health, the individual’s subjective evaluation serves to 




can be useful in that reduced HRQoL in FM is associated with increased use of healthcare 
resources (Kim, Kim, & Lee, 2012), poor prognosis of treatment (Torre, Martin-Corral, & 
Callejo, 2008) and increased levels of depression (Soriano-Maldonado, Amris, & Ortega, 
2015). Therefore, decreasing the adverse impact of FM on HRQoL should be a key focus 
for informing treatment development.  
The Medical Outcome Study 36-item Short Form Health Survey (SF-36) is one of the most 
widely used tools for assessing HRQoL (Garratt, Ruta, Abdalla, Buckinghamm & Russsell, 
1993). It defines HRQoL as the degree to which physical health affects an individual’s 
perceived functioning and well-being in relation to psychological, social and physical 
aspects of life (Ware & Sherbourne, 1992). The SF-36 is organised into eight subscales 
that evaluates: physical functioning (PF), physical role (PR), bodily pain (BP), general 
health (GH), vitality (VT), emotional role (ER), social functioning (SF) and mental health 
(MH). Scores on these subscales can be combined to form two higher-order summary 
scores, the Physical Component Summary (PCS) and Mental Component Summary (MCS). 
The PCS is calculated by positively weighting the four subscales in the physical domain 
(PF, PR, BP and GH) and the remaining mental domain subscales (VT, SF, ER, MH) 
negatively. In contrast the MCS is calculated by positively weighting the four mental 
domain subscales and negatively weighting the four physical domain subscales.  This 
measure has been found to be a reliable and a valid measure in FM (Timmerman, Calfa, 
& Stuifbergen, 2013), correlating well with disease-specific measures like the 
Fibromyalgia Impact Questionnaire-Revised (FIQ-R; Bennett, Friend, & Jones, 2009) and 
the Fibromyalgia Assessment Questionnaire (FAS; Salaffi, Sarzi-Puttini, & Girolimetti, 
2009). Research suggests that the SF-36 is a useful generic measure which can compare 
HRQoL between populations rather than providing a disease specific assessment such as 
the FIQ and the FAS. 
Increased levels of pain, physical disability, and mood disorders (anxiety and depression) 
have been associated with reduced quality of HRQoL for individuals with FM (Campos, 
2012). Studies suggest that several factors may affect HRQoL in individuals with chronic 
pain, such as gender, age, body mass index (BMI), disease severity, and duration of 
disease (Moradkhani, Beckman, & Tabibian, 2013; Faust, Halpern, Danoff-Burg, & Cross, 




impact of FM on HRQoL. Hoffman et al. (2008) has been the most recent systematic 
review which looked at health related quality of life in people with fibromyalgia 
compared to that of people in the general population and people with other long term 
conditions using the SF-36 and SF-12. While Hoffman’s (2008) review found that 
individuals with FM had significant impairments in both mental and physical health 
domains in comparison to the general population and individuals with specific pain 
conditions, it did not focus on the eight components of the SF-36 or the two higher order 
summary scores. Therefore, the present study will be the first to carry out a meta-analysis 
examining which specific components of the SF-36 are most effected for individuals with 
FM. Such information can highlight the specific areas where individuals with FM 
experience particular difficulty and allow healthcare providers to develop interventions 
for these specific difficulties. 
1.1.1 Aims of the Research:  
1. Systematically review the literature appraising the impact of FM on the eight 
subdomains of the SF-36 by providing a pooled meta-analysed mean score for 
each subdomain of the SF-36. 
2. To compare scores of individuals with FM on the SF-36 with aged matched healthy 
controls by providing a pooled meta-analysed mean difference score for each 
subdomain.  
3. To compare both meta-analysed pooled mean scores of Physical Component 
Scores (PCS) and Mental Component Scores (MCS) for individuals with FM to 
determine which is more severely affected by FM. 
4. To compare scores of individuals with FM on the PCS and MCS with aged matched 
healthy controls. 
 
1.2 Materials and Methods 
1.2.1 Search Strategy 
In order to identify eligible studies, systematic searches of the following databases were 




Embase 1947 to 2015 October 07, Psych Info 1806 to October Week 1 2015, Ovid Medline 
In-Process and Other Non-Indexed Citations and Ovid Medline (R) 1946 to Present) and 
EBSCOHost (incorporating CINAHLPlus and ERIC) online databases. Search terms were 
developed (Table 1.1) with reference to common key words and were searched for within 
titles, keywords, abstracts. Since the SF-36 was developed in 1992, the search was 
restricted from January 1992 to October 2015. Following search completion, titles and 
abstracts were initially screened to eliminate studies not meeting the inclusion criteria. 
The remaining studies were read in full to determine appropriateness for inclusion. 
 
Table 1.1 Electronic Database Search Terms 
Electronic Database Search Term 
(1)              Fibromyalgia 
(2)              Health Related Quality of Life  
(3)              Quality of Life 
(4)              Health Status 
(5)              HRQoL 
(6)              QoL 
(7)              Short Form 36 
(8)              SF-36 
(9)              SF36 
(10) (2) or (3) or (4) or (5) or (6)             
(11) (1) and (10)            
(12) (7) or (8) or (9)            
(13) (11) and (12) 
 
1.2.2 Selection Criteria 
Studies were eligible for selection if they used quantitative methods and analysis, which 
focused on adult samples (defined as age > 18 years) with a diagnosis of FM based on either 
the 1990 or 2010 published classification criteria by the American College of Rheumatology 
(ACR). The review also required that the studies used the SF-36 version 1 to assess HRQoL 
rather than the SF-36 version 2 as they have different scoring systems which limits the 
comparability of the scores. While SF-36 version 2 has shown improvement over accuracy, 
reliability and validity compared to version 1, many studies in relation to rheumatic disorders 




Katz, 2010). In order to reduce publication bias, grey material including academic, doctoral 
and masters’ dissertations and other unpublished papers were included. Non empirical work 
such as book chapters or reviews were excluded. Addressing the review question involved 
including only case-controlled studies so that the HRQoL subdomain scores could be 
compared between individuals with FM and the general population. Theoretical or review 
studies were excluded. 
1.2.3 Data Extraction and Quality Assessment 
It is important to evaluate the methodological quality of studies in the systematic review so 
that the reliability and validity of the result can be predicted (Jarde, Losilla & Vives, 2013). 
Available tools for evaluating methodological quality are predominantly developed to 
evaluate treatment effectiveness using a randomised controlled trial design e.g. the Centre 
for Reviews and Dissemination (CRD, 2008). As the eligible studies in this review are 
observational studies, such checklists would not be compatible. While reporting on quality 
of observational studies has increased in recent times (Mallen, Peat, Croft, 2006) systematic 
reviews on quality assessment tools for evaluating observational studies have concluded that 
no single tool has been found to be reliable (Sanderson, Tatt, & Higgins, 2007). The 
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE; 
Vandenbroucke, von Elm, Altman, et al, 2007; vonElm, Altman, Egger et al, 2007) is supported 
by the Cochrane Collaboration and contains a checklist of recommendations of items to be 
included in reports of observational studies in epidemiology. However, it was not designed 
to evaluate methodological quality, therefore, for this review an assessment tool was 
developed and adapted from a number of sources including the STROBE (Kmet, Lee, & 
Cook,2004), York’s Centre for Reviews and Dissemination guidance for undertaking reviews 
in healthcare (CRD, 2008) and Scottish Intercollegiate Guidelines Network (SIGN, 2008). The 
final assessment tool (Appendix B) has a total of five quality criteria which include the 
domains of selection bias, statistical power, measure validity and method of analysis. Four 
categories were arbitrarily established for quality assessment: ‘yes=2’, ‘partial=1’, and ‘no or 
not applicable=0’. In keeping with the guidance of the CRD (2008), a total numerical score 
was not calculated for the quality of each paper (Juni, Witschi, Bloch, & Egger, 1999). All 
studies were rated according to the quality criteria by the author and two independent 




Discrepancies were resolved through discussion and re-examination of the studies. The 
quality ratings assigned for each paper are summarised in Table 1.2. In an attempt to retrieve 
missing or incomplete data particularly MCS and PCS scores, emails were sent to all authors 
of the studies that were included in this review. 
1.2.4 Statistical Analysis 
The eight subdomain scores of the SF-36 for individuals with FM and control groups in each 
study were extracted as mean totals and mean differences (MD) ±SD. In addition, pooled 
means for PCS and MCS scores in the FM sample were meta-analysed for six of the studies 
that reported these values. Mean differences for the PCS and MCS were calculated and 
compared within the group of individuals with FM to determine whether there was a 
significant difference between the two components in this group. The PCS and MCS scores 
were also compared between individuals with FM and the healthy controls using mean totals 
and standard deviations. The OpenMeta-Analyst (Wallace, Dahabreh, Trikalinos et al., 2012) 
programme calculated scores in all studies eligible for the meta-analysis with 95% confidence 
intervals and combined by using random effects model (DerSimonian-Laird random effects 
method). Heterogeneity was assessed using the value of I², whereby 25%, 50% and 75% 
indicated low, moderate and high heterogeneity respectively (Higgins, Thompson, Deeks, & 
Altman, 2003). Heterogeneity was found to be high between studies, therefore sensitivity 
and subgroup analyses were conducted. 
 
1.3 Results 
1.3.1 Search Results 
Electronic databases were searched on 7th October 2015, with a return of 986 studies. 
Following removal of duplicates, there were 633 studies. First, titles of articles were screened 
resulting in the exclusion of 183 studies. Secondly, abstracts were reviewed and 341 were 
removed due to not meeting eligibility criteria for inclusion. Reference lists of all 109 studies 
that met the inclusion criteria were read in full. The 91 studies that were excluded at this 
stage are outlined in Appendix C.  Eighteen studies were identified that met the inclusion 




analysis. This process is summarised in Figure 1.1 by a flowchart based on the PRISMA 
statement. 
1.3.2 Characteristics of Included Studies 
Table 1.3 provides a summary of descriptive characteristics and key findings of the 18 studies 
included in this systematic review. The included studies were all case-controlled cross-
sectional studies published between 2000 and 2015. All studies included in the review used 
the 1990 American College of Rheumatology. Studies differed by country of origin and used 
translated versions of the SF-36 including Turkish (Akkaya et al., 2012; Alanoglu et al., 2005; 
Batmaz et al., 2013; Birtane et al., 2007; Tander et al., 2008; Turkyilmaz et al, 2012; Tuzun et 
al., 2004), Portuguese (Avila et al., 2014; Cardoso et al., 2011; Pagano et al, 2004), Spanish 
(Carillo et al, 2015; Segura-Jimenez et al., 2015), Italian (Salaffi et al., 2009), Hebrew 
(Neumann et al., 2000), Persian (Kolahi et al., 2010; Roshan et al., 2008) and Swedish (Andrell 
et al., 2014).     
1.3.3 Methodological Quality Assessment 
The methodological quality scores for each paper are provided in Table 1.2 According to the 
quality assessment tool, the majority of the studies included were of good methodological 
quality scoring highly across all criteria apart from the power/sample size. Ten studies were 
considered to be under-power (Alangolu et al., 2005, Avila et al. 2014, Batmaz et al., 2013, 
Birtane et al., 2007, Cardoso et al., 2011, Pagano et al., 2004, Smith et al., 2010, Tander et 
al., 2008, Turkyilmaz et al., 2012, & Tuzun et al., 2004).    
1.3.4 Sample characteristics 
There was marked variation in sample sizes with the number of individuals with FM ranging 
from 16 (Cardoso et al., 2011) to 459 (Segura-Jimenez et al, 2015). There was a total of 1733 
individuals with FM included in this review. The control group in this review had a sample 
size ranging from 16 (Cardoso et al., 2011) to 1579 (Salaffi et al., 2009), comprising of 3468 
in total. It was found that 15 studies recruited only females with FM, two studies included 
males with FM (Avila et al., 2014; Salaffi et al., 2009) and one study only included males with 
FM (Batmaz et al., 2013). The mean age of participants in the reviewed studies were 46 years 




(Akkaya et al., 2012; Alanoglu et al., 2005; Andrell et al., 2014; Avila et al., 2014; Batmaz et 
al., 2013; Birtane et al., 2007; Smith et al., 2010).  Overall studies tended not to include 
individuals over the age of 65. Five studies specified age restrictions such as 35-60 (Cardoso 
et al., 2011; Pagano et al., 2004; Roshan et al., 2008, Segura-Jimenez et al., 2015., Smith et 
al., 2010), however only one of these studies (Roshan et al., 2008) explored age as a 
confounding variable in relation to HRQoL. 
The majority of studies also had a trained health professional confirm the FM diagnosis rather 
than relying solely on self-report measures. Symptom severity of FM was measured using 
various psychometric measures in the reviewed studies. The Fibromyalgia Impact 
Questionnaire (FIQ) was administered in seven of the studies (Akkaya et al., 2012; Avila et al. 
2014, Birtane et al. 2007, Carrillo et al. 2011, Pagano et al. 2004, Tander et al. 2008, and 
Turkyilmaz et al. 2012), the Fibromyalgia Impact Questionnaire-Revised in one study (Segura 
et al., 2015) whereas a Visual Analogue Scale, tender point count and less well defined yes/no 
checklist of chronic symptoms were used in the remaining studies. Additionally, given the 
variation in measures used, the specific symptoms investigated within each of the individual 
studies also varied as did the intensity of the symptoms presented. 
1.3.5 Settings 
Individuals with FM were recruited from outpatient clinics and FM associations. Two of the 
studies included in the review used general population-based samples rather than healthcare 
settings (Salaffi et al. 2009; Smith et al., 2010). A benefit of using a general population sample 
was that results were not biased by help-seeking (Mas, Carmona, Valverde, 2008). 
1.3.6 Statistical Analysis 
A variety of statistical analyses were conducted across studies and ten of the studies had 
normally distributed data. T-tests and analyses of variance were the prominent statistical 
techniques to examine the difference between individuals with FM and healthy controls in 
relation to the SF-36 sub-domains. Four studies were awarded “yes” and fourteen received 
“partial” in relation to appropriate use of statistics. The studies that were awarded “yes” 
reported confidence intervals and effect sizes. Reporting of demographic information was 
variable. Some studies noted significant differences between individuals with FM and healthy 




in their analysis of SF-36 scores (Kolahi et al, 2010; Pagano et al. 2004). In order to explain 
the level of heterogeneity found, sensitivity analysis was conducted. 





















Number of record identified 













Number of records 
excluded based on 
details in title: (n=183) 
Number of full text reports 
screened for eligibility: 
(n=109) 
 
Number of studies included 
in the review: 
(n= 18) 
Number of records 
excluded based on 
details in abstract: 
(n=341) 
Number of full text 
reports excluded: (n=91) 
See Appendix C 
Table 1.2 Ratings of Study Quality for Included Studies 
 Sampling Design & Method Analysis 
Recruitment Method Fibromyalgia Measure Power & Sample Size Statistical Analysis Confounding Variables 
Akkaya, 2012 no yes partial yes yes 
Alanoglu, 2005 no no no partial yes 
Andrell, 2014 partial no yes partial no 
Avila, 2014 no yes no partial partial 
Batmaz, 2013 no no no partial no 
Birtane, 2007 no yes no partial yes 
Cardoso, 2011 no no no yes no 
Carillo, 2015 no yes partial partial no 
Kolahi, 2010 no no yes no yes 
Neumann, 2000 no no yes no no 
Pagano, 2004 no yes no partial partial 
Roshan, 2008 no no yes partial yes 
Salaffi, 2009 partial no yes yes yes 
Segura, 2015 partial yes yes yes yes 
Smith, 2010 partial no no partial yes 
Tander,, 2008 no yes no partial yes 
Turkyilmaz, 2012 no yes no partial yes 




Table 1.3 Summary of studies included in review. 
Author, Year, 
Country 
Sample Size Recruitment % female Mean Age (SD) Mean Disease 
Duration 
Measure of FM SF-36 PCS SF-36 MCS 
Akkaya et al., 2012 
Turkey 
 
FM= 51  CG= 41 
          
Outpatient FM=100  CG=100 
 
Total Sample=35.5(9.9) 2.8(2.2) FIQ 
FM= 70.8 (13.2) 
CG= 8.2 (9.6) 
  
Alanoglu et al., 2005 
Turkey 
 




FM=100  CG=100 
 
Total Sample=37(10) 1.5(1) TPC   
Andrell et al., 2014 
Sweden 
 
FM= 203  CG= 1055 
 
Outpatient FM=100  CG=52 
 




Avila et al., 2014 
Brazil 
 




FM=95  CG=90 
 




Batmaz et al., 2013 
Turkey 
 




FM=0  CG=0 
 
Total Sample= 37.2(8.4) 
 
 VAS   
Birtane et al., 2007 
Turkey 
 






Total Sample= 45.8(7.0) 
 
 FIQ   
Cardoso et al., 2011 
Brazil 
 




FM=100  CG=100 
 
FM=53.5(7.5)  CG=54.1(4.4) 
 
 SSB   
Carrillo et al., 2015 
Spain 
 
FM= 52  CG= 55 Outpatient 
 
FM=100  CG=100 
 





Kolahi et al., 2010 
Iran 
 




FM=100  CG=100 
 
FM=49.9(7.7)  CG=46.6(6.5) 
 




Neumann et al. 2000 
 Israel 
 
FM= 90  CG= 50 Outpatient 
 
FM=100  CG=100 
 
FM=48(10)  CG=55(13) 
 
10(3) VAS   
Pagano et al., 2004 
Brazil 
 




FM=100  CG=100 
 
FM=49.5(6)  CG=49.5(6) 
 
 FIQ   
Roshan et al., 2008 
Iran 
 




FM=100  CG=100 
 
FM=42.9(9.1)  CG=37.2(10.3) 
 




Salaffi et al., 2009 
Italy 
















FM= 459  CG=214 FM 
Association 







Smith et al., 2010 
USA 
 




FM=100  CG=100 
 
Total Sample= 48.4 (6.9) 
 




Tander et al., 2008 
Turkey 
 




FM=100  CG=100 
 
FM=40.0(1.1)  CG=40.4(1.0) 
 
5.23(0.9) FIQ=51.70(2.26)   
Turkilmaz et al., 2012 
Turkey 
 




FM=100  CG=100 
 










Tuzun et al., 2004 
Turkey 
 




FM=100  CG=100 
 
FM=41.6(7.3)  CG=38.9(5.4) 
 
8.6(6.6) VAS   











1.3.7 Meta-analysis of the eight subdomains of the SF-36 
The pooled mean scores on the eight SF-36 subscales for individuals with FM (Table 1.4), with 
95% confidence intervals (CI) indicates that the least affected subdomain on the SF-36 is Social 
Functioning. The worst affected subdomain for individuals with FM appears to be Physical 
Role. The subdomains related to physical health apart from Physical Functioning (Physical 
Role, Bodily Pain, and General Health) showed lower mean scores than the subdomains 
related to mental health apart from Vitality (Emotion Role, Social Functioning and Mental 
Health).  
 
Table 1.4 FM Participants Meta-analysed Pooled Mean Scores of the SF-36 subdomains (each 
subscale score from 0-100; higher scores indicates better HRQoL) 
SF-36 
Subgroups 





49.89 45.38 , 54.40 96.58 
Physical Role  
 
28.37 21.37, 35.37 98.14 
Body Pain 
 




39.33 34.67, 43.98 97.81 
Vitality 
 








42.68 36.63, 48.74 96.03 
Mental 
Health 
50.81 46.99, 54.62 96.14 
 
Table 1.5 presents the pooled mean differences between individuals with FM and healthy 
controls.  Forest plots of each domain meta-analysis can be found in Appendix E. On all eight 




healthy controls with the healthy controls reporting a significantly better level of HRQoL.  
Appendix F includes forest plots for the differences between individuals with FM and healthy 
controls with regards to the meta-analysed SF-36 subdomains. The greatest difference 
appeared to be in relation to the subdomains of Physical Role, Emotional Role, Bodily Pain 
and Physical Functioning. 










-33.92 -40.31 , -29.53 95.87 
Physical Role  
 
-53.39 -62.92, -43.87 97.92 
Body Pain 
 




-31.11 -35.91, -26.31 95.45 
Vitality 
 








-37.48 -45.92, -29.03 96.33 
Mental 
Health 
-21.24 -24.82, -17.65 91.57 
 
1.3.8 Meta-analysis of the two subcomponents of the SF-36 (PCS and MCS) 
The pooled overall scores for PCS and MCS for six studies that reported these components 
was 38.8 (95% CI: 31.2-46.4) and 42.3 (95% CI: 34.3-50.2). Figure 1.2. It was found that there 
were no significant differences between the PCS and MCS scores for individuals with FM (MD-







Figure 1.2 Meta-analysed difference between PCS and MCS for FM individuals 
 
Figure 1.3 presents the forest plots representing the pooled mean differences for PCS and 
MCS between individuals with FM and healthy controls.  Six studies compared scores on the 
PCS in individuals with FM and healthy controls. Individuals with FM had significantly lower 
scores on the PCS compared with healthy controls (MD-22.07; 95% CI, -28.95, -15.20 with 
high heterogeneity among studies I²= 98.58).  Six studies compared scores on the MCS in 
individuals with FM and controls. Individuals with FM had significantly lower scores on the 
MCS compared with healthy controls (MD-16.59; 95% CI, -21.38, -11.80 with high 
heterogeneity among studies I²= 94.74).  It can be seen that there were greater differences 
between the individuals with FM and healthy control on the PCS compared to the MCS. 
Figure 1.3 Meta-analysed difference between PCS and MCS in individuals with FM 
compared to healthy controls 
  






1.3.9 Sensitivity and subgroup analysis 
Appendix G presents the pooled mean differences between individuals with FM and healthy 
controls on the SF-36 sub-domain scores according to each sensitivity and subgroup analysis. 
Sensitivity analysis explored the exclusion of studies that did not receive a ‘yes’ or in some 
cases ‘partial’ on the methodology quality criteria in relation to sampling methods; measures 
of FM symptom severity, power/sample size; reporting effect sizes and p-values; and 
controlling for confounding variables. The subgroup analyses were conducted according to 
area of origin.  
The sensitivity analysis found that the level of heterogeneity remained in the high range 
(I²=>75) despite excluding studies based on the quality of the methodology. After excluding 
14 studies for using convenience sampling, the four studies that were awarded ‘partial’ 
(Andrell, 2014; Salaffi et al., 2009; Segura-Jimenez et al., 2015; Smith et al., 2010) showed a 
reduction in heterogeneity on BP(I²=11.1) and MH (I²=0) sub-domains. The subgroup analysis 
indicated that area of origin did reduce heterogeneity: on PF (I²=0), PR (I²=0), GH (I²=50.1), VT 
(I²=0), ER (I²=0) for Iran/Israel (Kolahi et al, 2010; Roshan et al., 2008); on PF (I²=49.39), BP 
(I²=43.25), and MH (I²=49.34) for America/South America (Avila et al., 2014; Cardoso et al., 
2011; Pagano et al., 2004; Smith et al., 2010); and on MH (I²=0) for Europe/Scandinavia 
(Andrell et al., 2014; Carrillo et al., 2015; Salaffi et al., 2009; Segura-Jimenez et al., 2015). 
Heterogeneity remained in the high range for all Turkish (other) studies (Akkaya et al., 2012; 
Alanoglu et al., 2005; Batmaz et al., 2013; Birtane et al., 2007; Neumann et al, 2000; Tander 
et al., 2008; Turkyilmaz et al., 2012; Tuzun et al., 2004). Sensitivity and subgroup analysis were 
not conducted to explore heterogeneity for the PCS and MCS scores as there were only six 
studies (Egger, Smith, Schneider, & Minder, 1997).  
1.3.10 Narrative synthesis of key findings 
In total, 11 out of 18 studies included in the review reported a significant difference in all 
subdomains of the SF-36 between individuals with and healthy controls (Alanoglu et al., 2005; 
Andrell et al. 2014; Avila et al. 2014, Batmaz et al., 2013; Birtane et al., 2007; Carillo et al 2014; 
Pagano et al. 2004; Salaffi et al. 2009; Smith et al., 2010; Segura-Jimenez et al., 2015; Tuzun 




This meta-analysis calculated that Physical Role compared to the other eight SF-36 
subdomains showed the greatest difference between individuals with FM and healthy 
controls. The forest plots (Appendix F) demonstrated that Pagano et al. (2004) compared to 
the other studies in the review reported the greatest difference between the FM group and 
the HC group in relation to PR. Pagano et al. (2004) matched controls for age and BMI, which 
received a ‘partial’ quality criteria rating for addressing confounding variables. The FIQ was 
also used but Pagano et al. (2004) did not report the total score of the FIQ or the mean 
differences between the FM and HC group to show the difference in severity of symptoms 
between the two groups. Turkyilmaz et al. (2012) on the other hand did not find any 
significant difference between the individuals with FM and healthy controls on the PR 
subdomain, however this study controlled for a number of variables which are known to 
impact quality of life e.g. BMI, marriage, education, occupation, economic status, mood. In 
term of addressing confounding variables on the methodology quality criteria, this study was 
awarded ‘yes’. The FIQ was also used in this study and it was found that while there was a 
significant difference between individuals with FM and healthy controls, the total figures 
reported for the healthy controls were slightly higher than what has been previously reported 
in other studies (Akkaya et al., 2012; Sivas, Baskan, Aktekin, 2009). This may indicate that 
there was a slightly higher level of symptom severity in the control sample which may explain 
the lack of significant difference between individuals with FM and healthy controls in relation 
to this subdomain. This is in line with the finding that there is a strong correlation between 
the FIQ and the PR subdomain (r=0.481; p< 0.007; Birtane et al., 2007). Cardoso et al., (2011) 
also did not report a significant difference on PR along with four other subdomains (VT, SF, 
ER, and MH). It must be noted that Cardoso et al., 2011 reported the smallest sample size 
(N=16) of all the studies in this review and received a ‘no’ rating on the methodology quality 
criteria for power. It is likely that the lack of significant differences between individuals with 
FM and healthy controls were a result of the study being insufficiently powered. 
While this meta-analysis found PR to be the subdomain which was most negatively affected 
in the FM group compared to the HC group, the SF subdomain was reported to be the least 
negatively impacted between these two groups. Four of the 18 studies (Akkaya et al. 2012; 
Cardoso et al., 2011; Roshan et al., 2008; Turkyilmaz et al., 2012) reported that SF was not 




interest was Roshan et al., (2008) study whereby SF score was found to be higher in individuals 
with FM than the healthy controls. Roshan et al. (2008) controlled for marital status, 
education, occupation as well as age which may have resulted in them finding a similar SF and 
MH score in both individuals with FM and healthy controls. Two other studies in this review 
also found that MH was not statistically significant (Tander et al., 2008; Cardoso et al., 2011). 
Tander et al., (2008) assessed for depression by using the Beck Depression Inventory (BDI) 
whereby a score of >17 was considered to be a sign of depression. It may be that individuals 
with FM and healthy controls did not differ significantly on MH because the BDI eliminated 
the possibility of individuals with co-morbid depression.  
Ten studies (Alanoglu et al., 2005; Andrell et al., 2014; Avilia et al., 2014, Birtane et al., 2007, 
Cardoso et al., 2011,  Kolahi et al., 2010, Pagano et al., 2004, Roshan et al., 2008, Salaffi et al., 
2009, Smith et al., 2010)  in this review did not use any standardised depression measure to 
account for co-morbid depression which may increase the likelihood of a significant difference 
being present between individuals with FM and healthy controls on the MH subdomain as 
previous studies have indicated the high prevalence of co-morbid depression in individuals 
with FM (Fuller-Thomson, Nimignon-Young, Brennenstuhl, 2012). Two studies reported that 
when comparing individuals with FM and healthy controls they did not find a significant 
difference in all of the SF-36 domains, however these studies did not include p-values to 
specify which subdomains were insignificant (Kolahi et al., 2010; Neumann et al. 2000). For 
this reason, these two studies were awarded ‘no’ on the methodology quality criteria for 
statistical analysis as the lack of p-values limited the possibility of interpretation and 
comparability of results. 
In terms of the PCS and MCS component scores it was found there were no significant 
difference between these components in individuals with FM. All five studies showed a 
slightly higher mean score for PCS compared to MCS except for Salaffi et al. (2009). It may be 
worth noting that apart from Segura et al. (2015), Salaffi seemed to receive the best ratings 
across all the methodology quality criteria. In their study they found that the PCS was 
influenced by widespread pain, education level and BMI whereas MCS was correlated with 
widespread pain, sleep abnormalities, physical functioning, fatigue, gender and low 
educational level. As Salaffi et al. (2009) used a general population, this sample may be more 




Overall, the six studies seemed to confirm that the PCS is more severely affected in individuals 
with FM compared to healthy controls.  
 
1.4 Discussion 
Studies conducted across different geographical areas showed that individuals with FM had a 
consistent pattern of HRQoL impairment. Overall individuals with FM scored significantly 
lower on all eight health status domains compared with individuals in the general population. 
The results of this review show that individuals with FM have lower levels of HRQoL, in 
particular Physical Role. This is in line with previous literature which suggests that individuals 
with FM have poor scores on the physical dimensions of HRQoL (Campos et al., 2012). Social 
Functioning and Mental Health were the least affected subdomains in this review for 
individuals with FM. A study carried out by Alonso et al. (2004) that used the SF-36 across 
eight different countries found Social Functioning and Mental Health to be the least affected 
in relation to chronic illnesses. These results were consistent with a similar review carried out 
among individuals with rheumatoid arthritis (Matcham et al., 2014). The relatively low impact 
of these diseases on social functioning and mental health may be explained by individuals 
being able to adapt to the conditions of the disease and/or adopting new lifestyle behaviours. 
It may also be related to cultural aspects as it was found that social functioning was least 
affected in an Iranian study (Roshan et al., 2008). This is in line with other systematic reviews 
that have found social functioning to be the least affected subdomain in an Iranian population 
with rheumatoid arthritis (Shokri, Mottaghi, Qolipour, 2015) and an elderly population where 
it was suggested that individuals may be able to access social support from family and society 
due to the values and emphasis on community (Tajvar, Arab, Montazeri, 2008).  One reason 
that Roshan may have found higher rates of SF than the control group was that the study 
controlled for marriage, education and occupation which have been found to be predictors 
of better related quality of life for Iranians with rheumatoid arthritis (Shokri et al, 2015). 
The greatest difference between individuals with FM and healthy controls were in the 
domains of Physical Role, Emotional Role, Bodily Pain and Physical Functioning. Other studies 
have suggested that the functional loss through incapacity to work and drop in income 
because of pain and fatigue may impact on a person’s perceived health related quality of life 








The quality of studies appeared to be good, however the majority of studies used sampling 
criteria that limited their external validity due to a small number of studies investigating 
population based samples (Salaffi et al. 2009; Smith et al., 2010). Studies that used 
convenience sampling recruited participants from hospital outpatient clinics, which may 
represent the most affected individuals with FM. Therefore, these results may not be an 
accurate representation of the FM population (Mas et al., 2008). On the other hand, smaller 
sample sizes (Avila et al., 2014; Cardoso et al., 2011) may represent only patients who present 
themselves for research participation, who in turn, would usually represent a healthier 
patient group (Knudsen, Hotopf, Skogen, Overland, & Mykletun, 2010). 
This review focused on one specific factor, HRQoL, however the majority of studies in this 
review explored a broad range of factors relating to FM such as auditory event related brain 
potentials (ERBP; Alangolu et al., 2005). While ERBP was relevant to FM, it was not related to 
HRQoL in FM. Therefore, this approach may not be the most appropriate as it may result in 
participant fatigue, with participants completing large batteries of questionnaires (Johnson et 
al, 2011). Moreover, it possibly will result in Type 1 error by increasing the likelihood of false 
positives. A small number of studies (Neumann et al., 2000) controlled for this by using 
adjustments to the criteria for significance such as the Bonferroni correction. However, this 
could increase the likelihood of Type II error (Perneger, 1998), a preferable alternative would 
be to conduct studies that included a smaller number of factors which may be more relevant 
to HRQoL. 
Increased BMI, lower education levels, marriage status, lower employment have been 
associated with poorer SF-36 scores (Cherapanov, Palta, Fryback et al., 2011). These factors 
were controlled for in a number of studies, however only one study controlled for them using 
a multiple regression. For this reason, it was not possible to look at whether these factors 
predicted poor HRQoL in individuals with FM. Although individuals with FM and the control 
group were matched for age, some studies applied an age-criteria in order to match the 
groups (Cardoso et al., 2011; Pagano et al., 2004; Roshan et al., 2008; Segura-Jimenez et al., 




participants over the age of 65, limiting the generalisability of the impact of FM on quality of 
life in older adults. This further reduces the interpretation and comparability of studies.  
All studies used the ACR 1990 criteria for identifying FM rather the 2010 preliminary criteria. 
While there is good agreement between the 1990 and 2010 criteria, it has been argued that 
the 2010 criteria have lower specificity and higher sensitivity (Goldenberg, 2009). This finding 
suggests that there is a higher possibility that individuals with other functional diseases but 
not generalised pain may be identified as having FM when using the 2010 ACR criteria (Carrillo 
et al., 2015). All of the studies in this review included predominantly female populations, 
which is in line with the literature reporting that 90% of individuals with FM are women 
(Yunus, 2002). 
The high level of heterogeneity identified in the meta-analysis may be explained by variation 
in the study population including disease duration and symptom severity.  While a number of 
studies accounted for variables such as gender, ethnicity, and marital status, a number of 
studies did not assess severity of symptoms. Eight studies in the review used a standardised 
measure for symptom severity and only six of these reported the values. Individuals with 
Fibromyalgia are a heterogeneous group and the rating number and impact of different 
symptoms are expected to vary between different populations (Branco et al, 2010). Research 
in this area has proposed a model of clustering individuals with FM into two categories based 
on physical symptoms and psychological symptoms of the FIQ (de Souza, Goffaux, Julien et 
al., 2009; Calandre, Garcia- Carrillo, Garcia-Leiva, 2011). Therefore, it would be useful to carry 
out a meta-analysis in the future looking at the impact of symptoms using the FIQ on the eight 
subdomains of the SF-36 to see if this may help to reduce the level of heterogeneity in the 
research.  
Sensitivity analyses did not reveal that the results were sensitive to the study methodology 
except in relation to sampling. Random sampling or recruiting from a number of areas rather 
than convenience sampling seemed to reduce heterogeneity in BP and MH. It is surprising 
that heterogeneity was reduced in BP as pain tends to be variable among individuals with FM 
(Schaeffer, 1997) with average daily pain ratings varying in individuals depending on time of 
day (Okifuji, Bradshaw, Donaldson, 2011). Subgroup analysis in relation to geographical origin 
succeeded in reducing some of the heterogeneity. Reasons for this may be in relation to 




different cultural variation in both phrasing of items and responses and in interpretation of 
the concept of HRQoL (Bullinger, Alonso, Apolone et al., 1998).  
1.41 Strengths, limitation and implications for future research 
Limitations of this review were that all studies were cross-sectional and therefore causation 
of poor HRQoL in individuals with FM could not be inferred. However, this review indicates 
that the physical role is most negatively affected in individuals with FM and provides a 
rationale upon which more methodologically rigorous experimental studies can be 
developed. In particular, it would be useful to look at what factors may be predictive of poor 
scores on physical role e.g. physical activity (Kop, Lyden, Berlin, Ambrose, Olsen, 2005) in 
individuals with FM which could help to develop intervention studies. 
This study only considered studies that used the SF-36 to measure HRQoL, which may have 
excluded studies that were potentially relevant. For example, Mas (2008) recruited from the 
general population and compared HRQoL using the SF-12 in individuals with FM and healthy 
controls. This data would have been useful as the external validity of the study was strong, 
however, it would not have been possible to include in the meta-analysis. 
A strength of the current review was that authors were contacted for further information 
such as PCS and MCS scores. Therefore, by providing the two higher summary scores along 
with subdomain scores, this review was able to show that the impact is significant in both 
physical and mental domains. The findings from this review show that while scores on the 
physical domains were poorer than the mental domains, treatment of FM should incorporate 
interventions that target helping people to improve both physical and mental components. 
This suggestion is in line with the SIGN Guidelines (2013) for chronic pain stipulating that a 
multidisciplinary team should be involved with chronic pain conditions. They also suggest that 
people with pain conditions tend to focus more on physical symptoms, therefore when 
referring patients for psychological assessment it should be clarified that the aim of a 
psychological intervention is to increase coping skills and improve quality of life.  
Finally, many of the studies did not include information about severity of FM symptoms or 
mood ratings such as depression or anxiety, it was not possible to specify the association 




limitations suggested, indicates that further research is needed to confirm the findings of this 
study. 
In conclusion the review demonstrated that individuals with FM have a lower level of HRQoL 
particularly on the Physical Role domain. Considering the level of heterogeneity of the 
evidence, this conclusion should be interpreted with caution. As it was not possible to obtain 
individual patient data for this review, aggregate data was used, however individual patient 
data would be recommended for future research in this area as it can improve the quality of 
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Objectives: This study aims to explore the predictive role of self-compassion (self-warmth 
and self-coldness) and self-esteem in key outcomes of quality of life and disability in a 
chronic pain population. 
Methods: A quantitative cross-sectional design was used. Sixty participants, recruited 
through NHS chronic pain services and pain self-management groups, completed 
measures of pain severity, self-compassion, self-esteem, distress, quality of life and 
disability. Correlation and hierarchical regression were used to explore relationships 
between these variables. 
Results: Quality of life was lower than previous research, with females reporting higher 
levels of quality of life than males. After controlling for demographic and clinical variables, 
self-warmth was a significant predictor quality of life, however it was not predictive of 
disability. Neither self-coldness nor self-esteem were significant predictors of quality of 
life or disability.   
Discussion: Self–warmth is associated with better quality of life in people with chronic 
pain. Psychological interventions targeting the development of self-warmth attributes 
and skills may have beneficial effect in the psychological adjustment of people suffering 
with chronic pain. Further research is needed to replicate these findings with a larger and 
more representative sample. 
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Chronic pain has been defined by the Scottish Intercollegiate Guidelines Network as the 
experience of pain for at least three months that does not resolve with treatment 1. With 
a worldwide estimated prevalence of 19-34%, 2,3 chronic pain is estimated to be one of 
the conditions with greatest socio-economic costs.4 As the burden of chronic pain 
increases, predictors and outcomes of chronic pain have received growing attention 5. 
Psychological factors are widely accepted as influencing the relationship between chronic 
pain and outcomes such as disability and distress.6 Psychological approaches have been 
applied in chronic pain management and seem beneficial.7 However, psychological 
treatments for chronic pain have shown small effect sizes and further development is 
required 8. It has been suggested that a focus on understanding the treatment 
mechanisms or processes may help to increase the efficacy of these treatments.9 One set 
of processes that have started to receive growing attention in the area of chronic pain are 
those related to self or personal identity such as self-compassion and self-esteem.10  
2.1.1 Evidence for Self-Compassion as a Predictor 
It has been suggested that positive affect may provide a buffering function to health 
problems associated with negative emotions in patients with chronic illness 11. The role of 
self-compassion was explored in a chronic illness group and a cancer group in relation to 
psychopathology and quality of life 12. Pinto-Gouveia et al. (2013) used a two-factor model 
of the Self-Compassion Scale referred to as self-coldness and self-warmth and it was found 
that self-coldness was the best predictor followed by self-warmth for quality of life in the 
chronic illness group. However Pinto-Gouveia et al. (2013) also found that self-warmth 




(2013) study reported limited demographic and clinical information and controlled only 
for education level, therefore it was difficult to infer what factors may have influenced the 
differences between the groups e.g. gender, age, severity of pain. Several studies have 
revealed that pain severity and distress are factors that contribute to poor quality of life 
and disability.13,14 Participants in Pinto-Gouveia et al. (2013) study were predominantly 
female and middle aged. A recent meta-analysis by Yarnell et al., (2015) suggested that 
while gender differences on levels of self-compassion were significant, only a small effect 
size was observed.15 Neff and Pommier (2013) proposed that women are often assigned 
the role of caregiver in society, however they are less able than men to relate to 
themselves with the same level of compassion that they would show to others.16 It was 
also found that females tend to be more critical of themselves and demonstrate more 
negative self-talk than males.  Age has been found to reduce the effect of gender 
differences on levels of self-compassion.15 Ardelt et al (2010) argued that the 
understanding of common humanity is a wisdom that is more likely to increase with age 
regardless of gender because people have more life experience to reflect upon.17   
2.1.2 How Self-Compassion is conceptualised and measured 
Self-compassion has been defined as comprising three main components: 1) self-kindness 
in the absence of self-judgement or self-criticism; 2) common humanity whereby an 
individual perceives their struggle as part of a shared human experience rather than an 
isolated experience; 3) mindfulness without over-identification in relation to negative 
thoughts or feelings. It is argued that when these components interact, an individual has 
the tendency to be caring, warm and understanding towards oneself regardless of one’s 




Self-compassion has been suggested to improve awareness and emotion regulation 
associated with psychopathology 19-21. MacBeth et al. (2012) conducted a meta-analysis 
on the relevance of self-compassion for the emotional symptoms of anxiety, depression 
and stress.21 Findings showed that self-compassion is related to psychopathology, 
identifying a large effect size. Associations were reported to be significant regardless of 
clinical status, age or gender. This meta-analysis used the total score from Self-
Compassion Scale (SCS) 22 and the Self-Compassion Scale-Short Form (SCS-SF) 23 rather 
than specific subscale scores. A recent meta-analysis by Muris et al (In Press) focused on 
the subscales of the SCS and SCS-SF in relation to psychopathology.24 It was found that 
the associations between the negative subscales of the SCS (self-judgement, over-
identification, isolation) and psychopathology were significantly stronger than the 
positive subscales of the SCS (self-kindness, common humanity and mindfulness). This 
suggests that the use of a total compassion score of the SCS or SCS-SF, which includes the 
reversely scored negative subscales, will potentially result in an inflated association with 
symptoms of psychopathology. This would result in an overestimation of the presumed 
protective role of self-compassion in mental health problems. Including both positively 
and negatively worded items in questionnaires were introduced with the aim of reducing 
response bias, however studies have shown that it can potentially undermine the quality 
of the assessment.25 This may be the case for the SCS as a recent factor analysis did not 
support its construct validity when using a total score. 26, 27 For this reason, some 
researchers into self-compassion have started separating the positive (self-kindness, 
common humanity, mindfulness) and negative (self-judgement, isolation, over-
identificaion) aspects of self-compassion into two dimensions known as self-warmth and 




It has been suggested that to clarify the protective nature of self-compassion, it would be 
appropriate to discard self-coldness (self-judgement, isolation and over-identification) 
from the questionnaire and to focus solely on self-warmth (self-kindness, common 
humanity and mindfulness).15 In addition, compassion focused interventions have 
reported specific improvements in positive affect, but they do not seem to effectively 
reduce negative affect more than any other intervention 28, 29. This conclusion may be 
explained as a lack of large-scale, high-quality trials rather than the existence of negative 
evidence.30 
Although there is evidence to suggest that self-compassion is associated with increased 
motivation in relation to positive health behaviours,31 this element is not represented in 
the items of the SCS or SCS-SF. As a result, the three aspects of self-warmth (self-kindness, 
common humanity and mindfulness) are not necessarily distinctive of compassion but 
seem to tap a number of already known protective factors. For example, there is a vast 
amount of research evidencing that mindfulness on its own promotes well-being in 
chronic pain populations. 32  
Constructs such as belongingness 33 and self-soothing 34 closely resemble Neff’s 18 
dimensions of common humanity and self-kindness. It would be useful to explore which 
components of self-compassion are important within the context of psychopathology. 24 
This is also true for the relative importance of self-compassion as compared with other 
constructs that have been advocated in the positive psychology literature such as self-
esteem.24 Although global self-esteem is considered to be less stable and more reactive 
than self-compassion,35 both concepts are viewed as highly relevant for a person’s general 




in previous research.81,35-37 Thus, in order to study the unique relationship between self-
compassion and mental health problems, it seems important to control for global self-
esteem. 
2.1.3 Overlap with other concepts  
High self-esteem has been found to be a resource for coping with illness,38 buffering 
against depression, stress, and negative emotions.39,40 In particular, self-esteem has been 
linked to psychological adjustment in various chronic diseases such as cystic fibrosis, 
multiple sclerosis and HIV.41-43 Conversely, illness may impact negatively on self-esteem.44 
Self-esteem may be threatened by experiencing illness-related consequences, or by 
decreased coping with everyday life challenges.45,46 In turn, low self-esteem may lead to 
unhealthy behaviours in an attempt to self-regulate negative emotions.47 A previous 
longitudinal study suggests that low self-esteem causes more negative affect for chronic 
disease patients than healthy populations.39 As self-esteem can be an important coping 
resource, one of the concerns raised by the combination of low self-esteem and chronic 
illness is an increased difficulty in preventing the negative affect from developing into a 
more severe case of depression. Research demonstrated that patients with chronic pain 
who had lower self-esteem reported more negative affect, less positive affect and greater 
symptom severity than individuals with higher self-esteem.38 
Neff 48 distinguished self-compassion from the related construct of self-esteem by 
proposing that self-esteem is based on evaluating oneself in comparison with others 
whereas self-compassion is based on relating to oneself without self-evaluation or 
comparison. Despite the benefits of self-esteem, studies show that what people do to get 




and increased aggression.49,50 Reasons for this may be that self-esteem is often dependent 
on favourable comparison with others and successful attainment which results in 
fluctuation depending on one’s successes or failures.48 
A number of studies have been conducted to investigate the cognitive and emotional 
processes by which self-compassionate individuals manage negative life events.51 It was 
evidenced that self-compassion accounted for unique variance in the outcome variables 
when controlling for self-esteem. It was also reported that because self-compassion is not 
evaluation based, self-compassion appears to be a more stable and unconditional form of 
self-regard than self-esteem.35 It must be noted that the situations the participants were 
dealing with in these studies 51 were unchallenging such as receiving a poor grade on a 
test or neutral feedback in comparison to many of the hardships people encounter in daily 
life. Therefore, their research shows that being self-compassionate helps people deal with 
real and imagined negative events, but the question remains of the degree to which 
treating oneself kindly buffers people against the impact of severe challenges in everyday 
life such as chronic pain. 
In a study examining resilience levels in adults with congenital spinal bifida, it was found 
that chronic pain negatively impacted on self-esteem and self-compassion. This is in line 
with previous research in that disability severity can result in frustration and distress.52 
The findings that self-esteem and self-compassion correlate with resilience are consistent 
with the idea that having a source of positive self-regard and an ability to be kind to 
oneself is likely to promote positive adaptation when faced with adversity. A strong 




with previous findings 18,51,53, raising the question of whether these are psychological 
distinct constructs.  
2.1.4 Summary 
Research in chronic pain has tended to focus on specific diagnoses, such as neuropathic 
pain 54 and fibromyalgia,55 or on specific subgroups such as older people 56 and trauma 
survivors.57 This focus on specific diagnoses/subgroups is limiting because many people 
with chronic pain do not have a clear diagnosis or precipitant for their pain.58 For this 
reason, the present study did not focus on one particular pain condition. 
Given the growing interest in the association between emotion regulation problems and 
unhelpful forms of self-relating with chronic pain, understanding the role of self-
compassion and self-esteem may be potentially important variables in chronic pain in 
order to develop more effective treatment interventions. Muris et al. (In press) conducted 
a meta-analysis which found a significant link between self-warmth, self-coldness and 
mental health indicators.24 Self-compassion also predicts unique variance in mental health 
after controlling for self-esteem. It was suggested that it would be useful to explore 
whether a two factor model of the SCS (self-warmth and self-coldness) is a better fit as 
this model seems to have stronger psychometric validity in both clinical and non-clinical 
samples.59 A recent review of the literature indicated that the vast majority of studies 
(83.5%) relied only on the SCS or SCS-SF total score as an index of self-compassion.24 
Studies including self-esteem, self-warmth, self-coldness as predictors are limited in a 
clinical population and non-existent in a sample of participants with chronic pain. Previous 
literature has indicated that demographic variables such as age, gender and pain duration 




disability.15,60 For this reason, the current study will control for relevant demographic 
variables when investigating self-warmth, self-coldness and self-esteem as predictors of 
disability and quality of life. 
2.1.5 Aims 
The main aim of the study was to determine whether and to what extent self-warmth, 
self-coldness and self-esteem would be unique predictors for pain outcomes while 
controlling for relevant demographic and clinical variables. We predicted that self-warmth 
and self-esteem would be (positively) associated with quality of life and (negatively) 
associated with disability, severity of pain and distress. We predicted that self-coldness 
will be (negatively) associated with quality of life and (positively) associated with 
disability, severity of pain and distress. It was hypothesised that self-warmth and self-
coldness would be stronger predictors than self-esteem for pain outcomes, disability, and 
quality of life after controlling for known predictors such as demographic (e.g. gender and 
age) and clinical variables (e.g. distress and severity of pain) 
2.2 Method 
2.2.1 Design 
This study used a cross-sectional, questionnaire-based design to explore relationships 
between self-warmth, self-coldness, self-esteem, and pain outcomes (distress, disability 
and quality of life). Ethical approval was granted by the NHS South East Scotland Research 





During the period of February 2015 to February 2016, four hundred participants were 
invited to participate from the NHS Chronic Pain Service in Fife and Lothian, the NHS Fife 
Rheumatoid Disease Unit and the Fife Pain Association Scotland Self-Management 
Groups. Sixty individuals returned completed questionnaires (return rate= 15%). Forty 
percent of the responses were returned from the Chronic Pain Service in Fife and Lothian, 
eighteen percent from the NHS Fife Rheumatoid Disease Unit and forty-two percent from 
the Fife Pain Association Scotland Management Groups.  Non-identifiable demographic 
information was collected in order to establish the characteristics of the sample. A total 
of 39 individuals (65%) were female and 21 individuals (35%) were male. Their mean age 
was 53.08 years (SD = 14.49) and their mean duration of pain was 11.2 years (SD= 10.7). 
Mean self-reported pain intensity and pain inference measured by the Brief Pain 
Inventory- Short Form (BPI-SF),61 was 6.46 out of 10 (SD= 1.59) and 6.92 out of 10 (SD= 2). 
These pain scores for the BPI-SF subscales were similar to reported scores on the BPI-SF 
in other studies carried out in a chronic pain.62 Participants had a variety of pain sites, with 
joint pain being the most common (34%), followed by back pain (28%), all over body pain 
(17%), and right sided pain (7%). The remaining pain locations were neck and leg. They 
reported having had a variety of treatments, with prescribed medication, physiotherapy 
and reflexology being the most commonly reported treatments.  
2.2.3 Measures 
Permissions for the use of copyrighted questionnaires were received prior to 




Demographics Questionnaire: Participants were asked to provide non-identifiable 
demographic data including age, gender, pain duration, diagnosis, and who provided their 
diagnosis. 
Self-Compassion Scale: (SCS)22 contains 26-items assessing how people typically act 
towards themselves in adverse circumstances. There are three factors of positive self-
compassion: self-kindness; common humanity; and mindfulness, and three factors that 
focus on lack of self-compassion: self-judgement; isolation; and over-identification. This 
study obtained two separate scores for this scale: self-warmth (sum of three positive 
factors) and self-coldness (sum of the three negative factors). Responses to each item are 
measured on a five-point scale from “Almost never” to “Almost always”. The scale has 
good predictive, convergent and discriminant validity and has been shown to have good 
internal consistency when used with a pain population (0.91-0.95).60,63 Cronbach’s alpha 
for the Self-warmth subscale in this sample was .92. Cronbach’s alpha for the Self-coldness 
subscale in this sample was .91. 
The Rosenberg Self-Esteem Scale: (RSES)64 includes 10 statements related to feelings of 
self-worth or self-acceptance, and measures of global self-esteem. The response set for 
this scale was 1 (strongly agree) to 4 (strongly disagree) with total scale scores ranging 
from 10 (low self-esteem) to 40 (high self-esteem). The scale has good predictive, 
convergent and discriminant validity and 65 and has been shown to have good internal 
consistency when used in a clinical population for individual with HIV and Cystic Fibrosis 
with a Cronbach’s alpha ranging from 0.85 to 0.94. 43,66 Cronbach’s alpha for the RSES in 




Brief Pain Inventory- Short Form: (BPI-SF)61 comprised 15 items and assesses for the 
presence of pain, pain severity and functional interference from pain (general activity, 
mood, walking, relationships with others, sleep, normal work and enjoyment of life) in the 
last 24 hours. For these subscales a higher mean score indicates higher pain severity and 
pain interference. It also assesses the types of pain medications being used, the 
percentage of pain relief obtained from medications and considers the distribution of pain 
via a body map. The BPI-SF has been used extensively in clinical trials for pain and has 
been recommended as a reliable and valid measure.67 Internal consistency for the pain 
severity score and for the interference scale has been reported as ranging from 0.85 and 
0.88 respectively.68 Construct validity of the BPI-SF has been supported for the generic 
assessment of pain as well as specifically for low back pain and rheumatoid arthritis.69 
Cronbach’s alpha for the BPI-SF in this sample was .91. 
The Hospital Anxiety and Depression Scale: (HADS)70 is widely used for measuring anxiety 
and depression in clinical population with physical illness. It contains 14 items and 
requires the respondent to rate the degree to which they have experienced emotions 
relating to distress in the past week. This scale provides an overall measure of emotional 
distress as well as depression and anxiety subscale scores. All items are rated on a four-
point response scale (0-3). Cut off scores for both anxiety and depression are normal (0-
7), mild (8-10), moderate (11-15) and severe (16-21).70 A person with a total score of 15 
or more (15+) on the HADS is considered to experience clinically significant emotional 
distress. 71 Across a wide range of samples the reliability and validity of the HADS has been 
well established with a Cronbach’s alpha for each scale ranging between .67 and .93 72,73 




Pain Disability Questionnaire: (PDQ)74 incorporates a disability-related psychosocial 
component in addition to a physical functioning component related to pain. The 
psychosocial component consists of nine items and has a score range of 0-90, which 
measures how much pain effects mood, physical role, leisure activities. The functional 
status component contains six items and scores range from 0-60 and measures how much 
pain impacts on employment status, self-care, mobility and income. The PDQ yields a total 
functioning disability score ranging from 0 (optimal function) to 150 (total disability), using 
10 point Likert scale.75 The PDQ has good reliability with a Cronbach’s alpha of .96. The 
construct related validity of the PDQ was found to be excellent as it correlated well to 
both the Million Visual Analog Scale (0.65-0.81) and Owestry Pain Disability Questionnaire 
(0.55-0.80).74 Cronbach’s alpha for the PDQ in this sample was .92. 
Quality of Life Scale: (QOLS)76 is a 16 item questionnaire that measures physical and 
mental well-being, relationships with other people, social, community and civic activities, 
personal development and fulfilment, recreation and independence. Each item was 
scored 1-7 and the total score ranges from 16-112. A higher total score shows a higher 
QOL. This scale has shown good validity and test-retest reliability.7 Good internal 
consistency (α=0.88-0.93) was found in a number of studies with fibromyalgia participants 
and a coronary obstructive pulmonary disease population. 78,79 Cronbach’s alpha for the 
QOLS in this sample was.93. 
2.2.4 Procedure 
NHS professionals in the Pain Management and Rheumatoid services, and facilitators in 
the Pain Association Self-Management Groups provided people attending these services 




questionnaires (Appendix N) along with a general questionnaire collecting non-
identifiable demographic information (Appendix M). Individuals who were interested in 
taking part in the study were given the packs to take home which they could then post 
back to the researcher using an included pre-paid envelope. Consent to participate was 
provided by the return of the (anonymous) research questionnaires. The questionnaires 
were marked with a unique identifier code for each recruitment site. 
2.2.5 Statistical Analysis 
All statistical analyses were conducted using IBM SPSS Statistics Version 22. The 
computational and modelling tool PROCESS 80 for SPSS was used for mediation analyses. 
2.2.6 Power and Sample Size 
Power analyses were conducted to guide recruitment. As the relationships between self-
compassion, self-esteem and pain outcomes (disability and quality of life) had not 
previously been investigated in this population, a medium effect size was assumed 
(conservatively), based on previous studies between self-compassion and general 
psychopathology in adults (r = -0.54; 95% CI [-0.57, 0.51])21 and chronic pain population 
(r's ranging from - 0.50 to -0.52) 73,60. It was determined that in order to have .8 power to 
detect a medium effect size at an alpha level of .05 with six independent variables (gender, 
severity of pain, distress, self-warmth, self-coldness and self-esteem) and two dependent 
variables (disability, quality of life) a sample of 103 was required (G*Power Version 
3.0.10).  




Data was checked for missing items. Little’s Missing Completely at Random (MCAR) Test 
was found to be non-significant (χ²(72)= 65.74p<.69). As data was found to be MCAR, 
missing data was dealt with by using individual mean substitution.82 This meant that for 
measures where up to one item per subscale was missing but less than 10% of total scale, 
and where there was homogeneity within subscales, individual mean substitution was 
adopted i.e. the inputted value was calculated from the mean of the available items of 
that subscale/total scale for the given respondent. While internal consistency can be 
positively skewed by using this method, it does allow for data to be included where limited 
items are missing. A total of 10 cases had missing items replaced using this method.  
2.2.8 Tests of Reliability 
Cronbach’s alpha tests of internal consistency were calculated for key variables and 
subscales. Values above .7 are generally considered to suggest adequate levels of 
reliability.83 Within this study reliability for all subscales and scales ranged from 0.76 to 
0.93. 
2.2.9 Data Analysis 
Data was initially screened to ensure that assumptions of further analyses were met. 
Histograms and boxplots were examined to ensure no outliers were present. Assumptions 
of linearity and homoscedasticity were found to be met through examination of 
scatterplots. Pearson correlations were calculated between all predictor variables to test 
for multicollinearity. No extremely high correlations i.e. 0.9, were identified, suggesting 
that all items were suitable for inclusion in further analyses.83 The Shapiro-Wilk test at 





Independent t-tests were used to explore gender differences. Correlational analysis was 
used to examine how the demographic (age) and clinical variables (severity of pain, pain 
duration and distress) related to self-warmth, self-coldness, self-esteem and pain 
outcomes (quality of life and disability) to establish what variables to control for in the 
hierarchical regression analyses. Correlational analyses were also run to determine the 
relationship between self-warmth, self-coldness, self-esteem and the outcome variables 
(quality of life and disability). Following this hierarchical regression analyses using forced 
entry of three blocks were planned with self-warmth, self-coldness and self-esteem as the 
predictor variables and disability and quality of life as the dependent variables while 
controlling for gender, pain severity and distress.  
2.3 Results 
2.3.1 Descriptive Data 
Table 2.1 presents the difference between males and females in relation to mean and 
standard deviation (SD) for each measure completed in the study. For the total samples 
self-esteem scores produced a mean of 26 (SD 7.2). Average scores on the SCS subscales 
were 35.34 (SD= 11.68) for self-warmth and 43.78 (SD=11.65) for self-coldness. Mean 
scores on the HADS subscales were 11.56 (4.87) for anxiety and 9.88 (4.67) for depression 
and when classified according to clinical thresholds produced, 70% (N=42) were in the 
clinical range of symptoms for anxiety and 80% (N=48) for depression. Mean scores of 
63.67 (SD=18.58) and 93.12 (SD=26.61) were obtained for quality of life and disability 
respectively. 




Gender has been shown to be a significant influence on many aspects of life for adults 
with chronic pain.84 Preliminary two-tailed t-tests were conducted to compare scores of 
males (N=21) and females (N=39) on each measure (see Table 2). Females reported higher 
quality of life with the Cohen’s d indicating a medium effect size (0.7). No significant 
gender differences were found for levels of distress, pain severity, self-esteem, self-
warmth and self-coldness. Cohen’s d indicated small effect sizes for these non-significant 
mean differences. Significant gender differences found in relation to quality of life 
indicated that gender should be controlled for in the hierarchical regression where quality 





Table 2.1 Mean differences between genders on outcome measure scores 
*Gender difference significant at the level of p<.05 
95% bias corrected and accelerated confidence intervals based on 1000 bootstrap samples    
*Levene test significant 
 
 








t P-value 95% Confidence Interval 
Lower            Upper 
BPI-SF Pain Severity Subscale 
 
6.38 (1.6) 6.50 (1.6) .119 .28 .79 -.76 .99 
HADS TOTAL SCORE 
 
 
23.95 (7.3) 20.10 (9.0) 3.85 -1.79 .08 -8.18 .48 
Rosenberg Self-Esteem Total Score 
 








43.79 (12.0) 43.77 (11.6) -.02 -.00 .99 -6.52 6.49 
Quality of Life Total Score 
 
 
55.61 (17.3) 68.00 (18.0) 12.39 2.61 .01* 2.80 21.98 
Pain Disability Questionnaire Total 
Score 




2.3.3 Correlation Analysis 
Table 2.2 presents the results of the Pearson’s correlations among the measures of self-
warmth, self-coldness, self-esteem, severity of pain, quality of life, distress and disability. 
All variables were significantly correlated in the predicted directions.  Consideration was 
given to the inclusion of age and duration of pain as control variables within the regression 
analysis. However, age did not significantly correlate with either quality of life [CI-.14,.39] 
or disability [CI-.5,.08] and pain duration did not significantly correlate with either quality 
of life [CI-.19, .33] or disability [CI-.31,.29].   
2.3.4 Regression Analysis 
A four stage hierarchical regression was conducted with quality of life as the dependent 
variable, to explore the independent effect of self-esteem, self-warmth and self-coldness 
on quality of life while controlling for gender, severity of pain and distress. Data met the 
assumption of independent errors (Durbin-Watson= 1.9) and multi-collinearity was not 
deemed to be a concern as tolerance scores ranged from .29 to .8 and variance inflation 
factor (VIF) scores from 1.26 to 3.48 (O’Brien, 2007). When gender was entered in step 1, 
it explained 8.7% of the variance in quality of life. Entering severity of pain subscale at 
step 2 explained an additional 13% of the variance in quality of life.  HADS total score was 
entered in at step 3 which explained 42% of the variance in quality of life. Finally, RSES 
total score and the SCS subscales (self-warmth and self-coldness) were entered in at step 
4, explaining 8% of the variance in quality of life.  The model as a whole explained 70.6% 
of the variance in quality of life. Four variables made a statistically significant contribution 
to this model. In order of highest beta values: HADS total, self-warmth subscale, and BPI-




severity were associated with lower rates of quality of life. The positive co-efficient 
indicates that higher levels of self-warmth were associated with higher rates of quality of 
life. Coefficients for all variables, including those with a non-significant contribution to the 
model, are presented in Table 2.3.  
A second hierarchical regression analysis was performed to examine if self-warmth, self-
coldness and self-esteem made a unique contribution to disability outcomes after pain 
severity, and distress were accounted for in the analysis. BPI-SF pain severity subscale was 
entered in step 1 and explained 18% of the variance in disability. Entering HADS total score 
at step 2 explained an additional 17% of the variance in disability. RSES total score and the 
SCS subscales self-warmth and self-coldness were entered in at step 3. RSES total score 




Table 2.2 Pearson’s correlation coefficients for correlations of key variables, age and pain duration 
Based on 2000 bootstrap samples 
** Correlation is significant at the 0.01 level (one-tailed), * Correlation is significant at 0.05 level (one-tailed) 
 
1. 2. 3. 4. 5. 6. 7. 8. 
1. Rosenberg Self-Esteem Score 
        
2. Self-Warmth  
.482**  
      
3. Self-Coldness  
-.600** -.435** 
      
4. HADS Total 
-.661** -.485** .617** 
     
5. Quality of Life Scale 
.584** .603** -.496** -.786** 
    
6. Pain Disability Questionnaire 
-.519** -.349** .398** .538** -.649** 
   
7. BPI-SF Severity Subscale 
-.281* -.015 .162 .336** -.344** .436** 
  
8. Age 
.235* .227* -.150 -.261* .124 -.214 -.056 
 
9. Pain Duration 




Table 2.3 Summary of Hierarchical Regression to predict quality of life 
95% bias corrected and accelerated confidence intervals based on 1000 bootstrap sample
Variable β 95% CI 





R R² Δ R² 
Step 1 .32 .10 .09 
Gender -12.39 -22.01              -2.77 -.32 -2.58 .01    
Step 2 .48 .23 .20 
Gender -12.89 -21.89              -3.89 -.33 -2.87 .01    
BPI-SF Pain Severity  -4.17 -6.91                -1.44 -.36 -3.06 .00    
Step 3 .81 .65 .63 
Gender -6.64 -12.93              -0.35 -.17 -2.11 .04    
BPI-SF Pain Severity  -1.30 -3.28                 0.68 -.11 -1.31 .19    
HADS Total  -1.53 -1.91                -1.16 -.71 -8.25 <.00    
Step 4 .86 .74 .71 
Gender -7.63 -13.37              -1.89 -.20 -2.67 .01    
BPI-SF Pain Severity  -1.96 -3.79                 -0.13 -.17 -2.15 .04    
HADS Total -1.10 -1.59                -0.62 -.51 -4.59 <.00    
Self-Warmth  .528 .25                      .80 .33 3.88 <.00    
Self-Coldness  .013 -30                      .32 .01 .08 .93    




Table 2.4 Summary of Hierarchical Regression to predict pain disability 
95% bias corrected and accelerated confidence intervals based on 1000 bootstrap samples 
Variable β 95% CI 
Lower           Upper 
Β 
standardised 
t p-value R R² Δ R² 
Step 1 .44 .19 .18 
BPI-SF Pain 
Severity 
7.32 3.34                11.29 .44 3.69 <.00    
Step 2 .60 .36 .34 
BPI-SF Pain 
Severity 
4.82 1.05                8.60 .29 2.56  .01    
HADS Total 1.36 .668                 2.06 .44 3.93 <.00    
Step 3 .64 .41 .36 
BPI-SF Pain 
Severity 
4.96 1.12                   8.79 .30 2.59   .01    
HADS Total  0.67 -0.30                  1.65 .22 1.38      .17    
Self-Warmth       -0.27 -0.85                     .30 -.12 -.95  .35    
Self-Coldness  0.08        -0.57                     .73 .04 .25 .80    




This cross sectional study aimed to explore the role of self-warmth, self-coldness and self-
esteem as predictors of quality of life and disability in a chronic pain sample. The results of 
the study will now be considered in relation to the initially outlined aims and hypotheses. 
Results showed that participants’ levels of self-esteem,85 pain severity,62 disability,74 and 
distress 86 were in line with previous studies using a chronic pain sample. Quality of life was 
slightly lower in this study than in previous studies 77,87 and it was not possible to compare 
the self-warmth and self-coldness subscales as they have not been specifically assessed in a 
chronic pain sample. Mental health symptoms were at clinical level for 77% of the sample, 
which is consistent with other studies indicating elevated mental health difficulties in a 
chronic pain population.88 Overall these scores suggest that the study sample was 
representative of a chronic pain population. One potential reason for the lower overall mean 
levels of quality of life in this study was the significant gender difference between male and 
females on this measure. Gender differences on levels of quality of life in a chronic pain 
sample remain inconclusive as a number of studies have found males to have higher quality 
of life 89 while others 87 did not confirm any significant differences. Rustoen90 reported similar 
results to this study where they found that females reported higher quality of life compared 
to males. One possible explanation for higher quality of life scores in women in this sample 
may be that men and women cope differently with chronic pain 91. While men tend to use 
behavioural distraction and problem-focused tactics to manage pain, women tend to use a 
range of coping techniques including social support, positive self-statements, emotion-




Correlation analyses revealed that higher self-esteem, higher self-warmth and lower self-
coldness were related to lower levels of distress, lower disability and better quality of life.60,38 
It was found that age was significantly related to higher self-esteem, self-warmth, and lower 
distress. This is in line with other studies which suggest that self-compassion on well-being 
has been shown to be more beneficial to middle-aged adult than those in early adulthood.93 
It may be that an understanding of common humanity increases with age.17 
The significant relationship between higher pain severity, higher distress, higher disability and 
lower quality of life are consistent with the results of previous research.6,12 The significant 
relationships found within this study were in contrast to previous findings in a chronic illness 
group whereby self-compassion and self-esteem did not correlate significantly with lower 
disability.52 Our findings indicate that having a salient source of positive self-regard and an 
ability to be kind to oneself is likely to promote positive adaptation when faced with adversity. 
Previous literature has reported the strong correlation between self-esteem and self-
compassion, suggesting that the two constructs are not psychologically distinct. This study 
found that while self-coldness strongly correlated (-.6) with self-esteem, self-warmth only 
demonstrated a medium correlation (.42) with self-esteem. Muris et al. (in press) 94 reported 
a similar correlation between self-warmth and self-esteem (.44). They noted that common 
humanity which is a component of this subscale did not correlate significantly with global self-
esteem, possibly because self-esteem is more concerned with comparing oneself to others 
rather than feeling connected to others. Nevertheless, the correlation between self-warmth, 




35 and the magnitude of the inter-correlations demonstrate that self-warmth, self-coldness 
and self-esteem appear to be distinct but related to aspects of personal identity. 95 
Hierarchical regression revealed that self-warmth was a significant predictor of quality of life 
after controlling for gender, pain severity and distress. Self-coldness was not found to be a 
significant predictor for quality of life. These findings were in line with previous research 
carried out among patients with chronic illness and cancer.12 These studies found that self-
warmth was the only predictor for quality of life among cancer patients. However, Pinto-
Gouveia et al., 2013 also reported that self-coldness explained the majority of the variance 
for quality of life in patients with chronic illness.12 It would be expected that the results of 
this study should be more in line with the chronic illness patient group rather than the cancer 
patient group in Pinto-Gouveia et al. (2013) study.12 However, their study did not contain a 
pain severity measure and therefore it may be that the cancer patients experienced more 
pain severity 96 than the chronic illness group, which might account for the similarities 
between the chronic pain sample in the present study and the cancer group in Pinto-Gouveau 
et al. (2013) study.12  These findings seem to support the theory that the way self-compassion 
enhances positive wellbeing is via the increased self-kindness, common humanity, and 
mindfulness associated with a compassionate mind state. It must be noted that distress was 
the more important predictor of quality of life than the other predictors in the model. Distress 
was added to the forced entry regression before self-coldness and it is likely that this reduced 
the predictive power of self-coldness in this model. This study and previous studies have 
reported significantly high correlations between self-coldness and distress compared with 




that although the protective influence of self-warmth exists in relation to psychopathology, 
the effect is likely to be boosted when self-coldness is also included.24 
The hypothesis that self-esteem would be a significant predictor for quality of life was not 
supported in this study. The finding may be a result of the measure used for quality of life in 
that the QOLS does not contain subscales separating out physical and psychological 
components of quality of life like the SF-36.97 In a study looking at multiple sclerosis, it was 
found that self-esteem only explained the variance on the Mental Component Scale (MCS) 
rather than the Physical Component Scale (PCS) of the SF-36.42 Self-esteem thus seems to be 
important in MCS, which is in line with previous findings in other chronic conditions.43,85,98 
Many studies used the SF-36 in medical setting for chronic illness or chronic pain and it may 
be that self-esteem is more likely to predict quality of life because self-esteem is a 
psychological variable and MCS may be considered predominantly of psychological or 
emotional nature. While self-esteem was not a predictor for quality of life, our findings 
support previous findings which reported that self-compassion would account for the unique 
variance in outcome variables when controlling for self-esteem. This study adds to the 
evidence base in that chronic pain is a more adverse life experience than the examples (e.g. 
poor grade on a test) that were used in other research when examining the differences 
between self-esteem and self-compassion in relation to psychological well-being.51 
The findings that neither self-warmth, self-coldness nor self-esteem were significant 
predictors of physical disability were contrary to our hypotheses that self-warmth or self-
coldness would be a stronger predictor than self-esteem for disability. In contrast other 




It must be noted that Wren et al. 60 recruited participants who had a >30 BMI, therefore it 
may be that self-warmth has the potential to act as a buffer against the mental and global 
health detriments of self-stigma which relate to disability in overweight and obesity 99 rather 
than chronic pain. Our study replicated findings from Hoge et al 100 in that they found that 
self-compassion correlated with disability in a group of people suffering from generalised 
anxiety disorder, however, self-compassion was not a significant predictor of disability. 
Instead they found that the non-judgment of inner experience component of mindfulness 
contributed to lower disability. This has also been reported in the chronic pain literature 32 
and it may be useful to further explore the subcomponents of self-warmth (common 
humanity, self-kindness and mindfulness) to explore which components correlate and predict 
a relationship with lower disability in chronic pain.  
2.4.1 Clinical Implications 
The current findings have important implications for clinicians working with this population. 
Clinicians should assess psychological constructs such as self-warmth and target interventions 
to promote this type of protective processes in an attempt to improve overall quality of life 
in people with chronic pain. There is rising evidence that self-warmth can be increased with 
practice 101 with many interventions having been proposed for people with chronic pain; 
loving kindness meditation;102 compassion meditation;103 positive psychology techniques;104 
and mindfulness.32 There is also research to suggest that third wave interventions such as 
Dialectical Behaviour Therapy (DBT)105 and Acceptance and Commitment Therapy (ACT)106 
may be useful due to their emphasis on mindfulness and concepts similar to over-




state that “good mental health is not potentiated solely by the absence of mental ill health 
but the presence of positive mental health factors”,108 it is suggested that increased 
knowledge on the role of self-compassion in adult mental health, particularly chronic pain 
settings, may provide and promote an alternative way to conceptualise chronic pain 
difficulties. 
2.4.2 Strengths and Limitations 
To the author’s knowledge, this study is the first to explore the role of self-warmth, self-
coldness and self-esteem as predictors of quality of life and disability in a chronic pain sample. 
The SCS is currently the most widely used measure of self-compassion, however concerns 
have been raised in relation to its underlying structure. Costa et al. (2015) did not replicate 
evidence for an overarching construct of self-compassion, suggesting that a two factor 
structure model is more appropriate.59 The present study used a two factor model to further 
investigate its utility in a clinical population. In addition, the study used standardised 
validated psychometrics with psychometric properties demonstrated both in previous 
research and replicated with the current sample. The sample was recruited from several sites 
in Scotland e.g. NHS and self-management groups, which may help to reduce biased results 
towards a specific demographic. Although a larger sample recruited from the community to 
increase the generalisability of findings would have helped to increase reliability of the study.  
The sample size was small due to a low response rate, however this is consistent with a postal 
survey response in a chronic illness group.52 The method for data collection may have created 




participate. The cross-sectional design prevents causal inference, therefore a suggestion for 
future research could conduct controlled studies in a laboratory setting where self-
compassion could be manipulated and the effects on key outcomes systematically assessed 
(e.g., severity of pain, distress, quality of life, disability). In addition, the present study relied 
on self-report measures. Future studies investigating the relationship between self-
compassion and pain adjustment should consider integrating self-report measures with direct 
measures, such as functional performance and structured clinical interviews. 
The results of the current study indicate a need for further research particularly in relation to 
longitudinal and experimental studies, explicitly testing causal chains such as those proposed 
in this study. This was the first study to explore self-warmth, self-coldness and self-esteem as 
predictors in a chronic pain sample, replication with a larger sample is necessary to 
strengthen the conclusion drawn and to ensure generalisability.  
2.4.4 Conclusion 
The current study expands the literature by demonstrating self-warmth as a unique predictor 
of quality of life when distress, severity of pain and gender were controlled for in a chronic 
pain population. It was also found that neither, self-warmth, self-coldness or self-esteem 
were unique predictors of disability when controlling for distress and severity of pain. The 
findings suggest that interventions which may increase self-warmth such as Compassionate 
Mind Training 101 would be an effective treatment in addressing poor quality of life for people 
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 Yes Partial No 
Sampling: The recruitment method 
The recruitment/sampling method ensures that minimal bias is 
introduced (e.g. recruitment from the general population) 
   
The recruitment/sampling method used random sampling    
The recruitment/sampling used a convenience sample    
Validated Method for ascertaining severity of Fibromyalgia 
The psychometric properties of the outcome measure for 
fibromyalgia are valid and reliable in this study population 
   
The measure has not been validated in this population    
The measure has not undergone any psychometric evaluation, or 
did not used a measure to assess severity of fibromyalgia 
   
Power and Sample Size 
The study has a sample size large enough to detect a small to 
moderate effect size with the statistical power of 0.8 at an alpha 
level of 0.05 
   
The study has a sample size large enough to detect a small to 
moderate effect size the statistical power of 0.7 at an alpha level 
of 0.05 
   
The study has a sample size large enough to detect a small to 
moderate effect size with the statistical power of less than 0.7 at 
an alpha level of 0.05 or power was not calculable 
   
Appropriate Method used 
The method of statistical analysis was appropriate to the research 
question being asked. Confidence intervals, p-values and effect 
sizes are reported. 
   
The analysis is appropriate however the findings are not reported 
in sufficient detail 
   
The method of analysis is not appropriate to the research question 
and does not provide meaningful results 
   
Confounding variables  
Potential confounding variables are adequately recognised and a 
description is provided on how they are addressed in statistical 
analysis 
   
Potential confounding variables are recognised and there is 
recognition of a possible  effect but they are not considered in 
statistical analysis 
   




Appendix C- Excluded Studies from Systematic Review 
Studies excluded Reasons for exclusion 
Full Article Review 
Alves, 2012 No control 
Amital 2014 Included both FM and Systemic sclerosis in the 
sample 
Andrell 2014 SF—36 were z scores 
Angst 2006 Needed to have had history of failed treatment 
to participate in the study 
Aparicio 2013 Did not include SF-36 subscales 
Aparicio 2014 Inclusion criteria obesity 
Arranz 2012 Split FM according to BMI 
Assis, 2006 No control 
Atagun, 2012 Duplicate 
Berfman, 2005 Did not include SF-36 subscales 
Boehm, 2011 Did not include SF-36 subscales 
Borsbo, 2010 Did not include SF-36 subscales 
Brattberg, 2008 Had to be non-working 
Brill, 2012 Did not include SD for SF-36 means 
Burckhardt, 2005 Did not include SF-36 subscales 
Buskila, 2000 Did not include SF-36 subscales 
Campos, 2012 No control 
Campos, 2013 Split FM into age cohorts 
Carbonell-Baeza, 2011 Did not include SF-36 subscales 
Cardona-Arias, 2014 No Controls 
Castellli, 2012 No Controls 
Chen, 2014 Conference abstract- unavailable 
Choy, 2009 Did not include SF-36 subscales 
Coster, 2008 Control group included people with pain 
DaCosta, 2000 Could not access article 
Danis, 2015 Abstract conference- unavailable 
De Araujo No control group 
Dell’Osso, 2011 Could not access article 
Dogramaci, 2009 Split FM into skin conditions 
Donaldson, 2001 No Control 
Glattacker, 2010 Treatment Groups 
Jensen, 2009 Did not include SF-36 subscales 
Jiao, 2015 Sample from a previous treatment group 
Jiao, 2015 Split FM into history of abuse 
Jiao, 2014 Divided into age cohorts 
Kim, 2012 Split FM into BMI 
Kim, 2012 FM in BMI 
Kim, 2013 Same data set 
Kim, 2012 Did not include SF-36 subscales 
Latorre, 2013 Treatment study 
Martinez, 2001 No standard deviation for the SF-36 subscales 
Matsumoto, 2011 No control 
Oliveiria, 2009 No control 




Peleg, 2008 No control 
Picavet, 2003 No control 
Raj, 2000 No control 
Rodero, 2010 No control 
Romero, 2012 Treatment control 
Rosenzweig, 2010 No control 
Sanudo, 2011 RCT- treatment 
Sanudo, 2012 RCT- same data as above 
Saxe, 2009 Did not include SF-36 subscales 
Schlenck, 1998 Did not include SF-36 subscales 
Schlenck, 1998 Used a CBT treatment groups 
Seo, 2010 Abstract Conference- unavailable 
Servant, 2011 Did not include SF-36 subscales 
Sigl-Erkel, 2011 RCT 
Silvas, 2009 RA control 
Slawsky, 2011 Used the Rand SF-36 
Taggart,  No control 
Theadorn, 2007 No control 
Trinanes, 2015 No control 
Tomas-Carus, 2009 No control 
Trovato, 2010 Did not include control 
Turan, 2011 No control 
Uhlemann, 2007 Did not include control 
Ulas, 2006 Duplicate datas 
Valim, 2002  Unable to access article 
Verbunt, 2008 Did not include SF-36 subdomains 
Vitorino, 2006 No Control 
Yilmaz, 2008 No Control 
Yoshikawa, 2010 Had to meet clinical cut-off for depression 
Walker, 1997 No Control 
Wang, 2010 RCT-did not include subdomains 
Wang, 2010 Did not include SF-36 subdomains 
Wolfe, 2013 Abstract Conference- Unavailable 
Wolfe, 2011 No control 
Wolfe, 2005 No control 
Wolfe, 2009 No control 
Wolfe, 2010 No control 
Wolfe, 2011 No control 
Wong, 2012 RCT-did not include subdomains 
Web of Science  
Efrati, 2015 Did not include SF-36 subdomains 
Plazier, 2015 Did not include SF-36 subdomains 
Wolfe, 2014 Did not include SF-36 subdomains 
Pedro, 2012 Split FM into severity  
Rombaut, 2011 Did not include SF-36 subdomains 
Ubago, 2007 Did not include SF-36  
Mease, 2008 Did not include SF-36 subdomains 





Appendix D: Systematic Review Data Extraction Form 
General Information 




Type of publication (e.g. journal articles, conference abstract) 
Country of origin 
 
Study Characteristics 
Aim/objectives of the study 
Study design 
Study inclusion criteria 
Study exclusion criteria 







Mean ± SD SF-36 subscales 







Number of participants enrolled in study 
Number of participants who provided valid data 
 
Method 
Scoring and use of SF-36 
FM measure 
Depression measure 
Setting in which the study is conducted 
Description of the controls 
 
Outcome data/results 
Additional measures/confounding variables 
Statistical analysis used  
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Appendix G - Sensitivity and Subgroup Analysis Table  
Sensitivity 
Analysis 
PF PR BP GH VT SF ER MH 
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INSTRUCTIONS FOR AUTHORS 
The Clinical Journal of Pain publishes original articles in the following forms: Clinical 
investigations: Present results of original clinical research. Case reports: Case reports will no longer 
be accepted for publication in Clinical Journal of Pain and thus no submission for case 
reports will be accepted as of June 13, 2013. Reviews: Comprehensive surveys covering a broad 
area. They consolidate old ideas and may suggest new ones. They must provide a critique of the 
literature. Special articles: On subjects not easily classified above (e.g., articles on history, education, 
demography, ethics, socioeconomics, etc.). Letters to the editor: These may offer criticism of 
published material, but must be objective, constructive, and educational. A few references, a small 
table, or relevant illustrations may be used. 
Ethical/Legal Considerations: A submitted manuscript must be an original contribution not 
previously published (except as an abstract or preliminary report), must not be under consideration 
for publication elsewhere, and, if accepted, must not be published elsewhere in similar form, in any 
language, without the consent of Lippincott Williams & Wilkins. Each person listed as an author is 
expected to have participated in the study to a significant extent. Although the editors and referees 
make every effort to ensure the validity of published manuscripts, the final responsibility rests with 
the authors, not with the Journal, its editors, or the publisher. All manuscripts must be submitted 
on-line through the journal's Web site at http://cjp.edmgr.com. See submission instructions 
under "On-line manuscript submission."  
 
Patient anonymity and informed consent: It is the author's responsibility to ensure that a 
patient's anonymity be carefully protected and to verify that any experimental investigation with 
human subjects reported in the manuscript was performed with informed consent and following all the 
guidelines for experimental investigation with human subjects required by the institution(s) with which 




figures unless they obtain written consent from the patients and submit written consent with the 
manuscript. 
Conflicts of interest: Authors must state all possible conflicts of interest in the manuscript, including 
financial, consultant, institutional and other relationships that might lead to bias or a conflict of 
interest. If there is no conflict of interest, this should also be explicitly stated as none declared. All 
sources of funding should be acknowledged in the manuscript. All relevant conflicts of interest and 
sources of funding should be included on the title page of the manuscript with the heading “Conflicts 
of Interest and Source of Funding:”. For example: 
Conflicts of Interest and Source of Funding: A has received honoraria from Company Z. B is currently 
receiving a grant (#12345) from Organization Y, and is on the speaker’s bureau for Organization X – 
the CME organizers for Company A. For the remaining authors none were declared. 
Copyright: In addition, each author must complete and submit the journal's copyright transfer 
agreement, which includes a section on the disclosure of potential conflicts of interest based on the 
recommendations of the International Committee of Medical Journal Editors, "Uniform Requirements 
for Manuscripts Submitted to Biomedical Journals" (www.icmje.org/update.html). 
A copy of the form is made available to the submitting author within the Editorial Manager submission 
process. Co-authors will automatically receive an Email with instructions on completing the form upon 
submission.  
 
Compliance with NIH and Other Research Funding Agency Accessibility Requirements 
A number of research funding agencies now require or request authors to submit the post-print (the 
article after peer review and acceptance but not the final published article) to a repository that is 
accessible online by all without charge. As a service to our authors, LWW will identify to the National 
Library of Medicine (NLM) articles that require deposit and will transmit the post-print of an article 
based on research funded in whole or in part by the National Institutes of Health, Wellcome Trust, 
Howard Hughes Medical Institute, or other funding agencies to PubMed Central. The Copyright 
Transfer Agreement provides the mechanism. 
Permissions: Authors must submit written permission from the copyright owner (usually the 
publisher) to use direct quotations, tables, or illustrations that have appeared in copyrighted form 
elsewhere, along with complete details about the source. Any permissions fees that might be required 
by the copyright owner are the responsibility of the authors requesting use of the borrowed material, 
not the responsibility of Lippincott Williams & Wilkins.  
 
MANUSCRIPT SUBMISSION 
On-line manuscript submission:All manuscripts must be submitted on-line through the Web 
site: http://cjp.edmgr.com. First-time users: Please click the Register button from the menu and 
enter the requested information. On successful registration, you will be sent an e-mail indicating your 
user name and password. Print a copy of this information for future reference. Note: If you have 
received an e-mail from us with an assigned user ID and password, or if you are a repeat user, do not 
register again. Just log in. Once you have an assigned ID and password, you do not have to re-




username/password at any time by clicking “Update My Information” at the top of any page in 
Editorial Manager. Authors: Please click the log-in button from the menu at the top of the page and 
log into the system as an Author. Submit your manuscript according to the author instructions. You 
will be able to track the progress of your manuscript through the system. If you experience any 
problems, please contact the Managing Editor, Julie Porter: JuliePorter529@gmail.com or 303-870-
6334 (phone). 
Preparation of Manuscript 
Cover Letter. With your manuscript, please submit a brief cover letter describing your manuscript 
and provide the names and e-mail addresses of 3-4 suggested reviewers. These should be people who 
are knowledgeable of the topic of the manuscript and who will not have a conflict of interest serving as 
reviewers. The Editors may or may not enlist these suggested reviewers.  
 
Manuscripts that do not adhere to the following instructions will be returned to the corresponding 
author for technical revision before undergoing peer review. 
General format: Submit manuscripts in English as a Word file. Double space all copy, including 
legends, footnotes, tables, and references. 
Title page: Include on the title page (a) complete manuscript title; (b) authors' full names, highest 
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author; and (e) sources of support that require acknowledgment. 
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organizations: National Institutes of Health (NIH); Wellcome Trust; Howard Hughes Medical Institute 
(HHMI); and other(s). 
Structured abstract and key words: Limit the abstract to 250 words. Do not cite references in the 
abstract. Limit the use of abbreviations and acronyms. Use the following subheads: Objectives, 
Methods, Results, and Discussion. List three to five key words. 
Text: Organize the manuscript into four main headings: Introduction, Materials and Methods, Results, 
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forms of support, including pharmaceutical and industry support, in an Acknowledgments paragraph. 
The Clinical Journal of Pain does not have a required number of words for the text. Please treat your 
subject thoroughly but not excessively. Perusing several back issues to familiarize yourself with typical 
accepted article length is recommended. 
Abbreviations: For a list of standard abbreviations, consult the Council of Biology Editors Style 
Guide (available from the Council of Science Editors, 9650 Rockville Pike, Bethesda, MD 20814) or 
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References: The authors are responsible for the accuracy of the references. References should be 
cited by number in order of citation in the text. Key the references (double-spaced) at the end of the 
manuscript, in numbered order. Cite unpublished data, such as papers submitted but not yet accepted 
for publication or personal communications, in parentheses in the text (H. E. Marman, M.D., 
unpublished data, February, 1997). If there are more than three authors, name only the first three 
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Journal article  
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Book chapter  
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Williams & Wilkins, 1999:205-256.  
 
Entire book  
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Wilkins, 1999.  
 
Software  
4. Epi Info [computer program]. Version 6. Atlanta: Centers for Disease Control and Prevention; 
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Online journals  
5. Friedman SA. Preeclampsia: a review of the role of prostaglandins. Obstet Gynecol [serial online]. 
January 1988;71:22-37. Available from: BRS Information Technologies, McLean, VA. Accessed 
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Database  
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March 29, 1996.  
 
World Wide Web  
7. Gostin LO. Drug use and HIV/AIDS [JAMA HIV/AIDS Web site]. June 1, 1996. Available 
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Figures: 
A) Creating Digital Artwork 
1. Learn about the publication requirements for Digital Artwork: http://links.lww.com/ES/A42 
2. Create, Scan and Save your artwork and compare your final figure to the Digital Artwork 
Guideline Checklist (below). 




B) Digital Artwork Guideline Checklist 
Here are the basics to have in place before submitting your digital artwork: 
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 Crop out any white or black space surrounding the image. 
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 Number figures in the figure legend in the order in which they are discussed. 
 Upload figures consecutively to the Editorial Manager web site and enter figure numbers 
consecutively in the Description field when uploading the files. 
Figure legends: Legends must be submitted for all figures. They should be brief and specific, and 
they should appear on a separate manuscript page after the references. Use scale markers in the 
image for electron micrographs, and indicate the type of stain used. 
Color figures: The journal accepts for publication color figures that will enhance an article. Authors 
who submit color figures will receive an estimate of the cost for color reproduction. If they decide not 
to pay for color reproduction, they can request that the figures be converted to black and white at no 
charge. 
Tables: Cite tables consecutively in the text, and number them in that order. Key each on a separate 
sheet, and include the table title, appropriate column heads, and explanatory legends (including 
definitions of any abbreviations used). Do not embed tables within the body of the manuscript. They 
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Supplemental Digital Content 
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standard media such as text documents, graphs, audio, video, etc. On the Attach Files page of the 
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LWW staff, they will be presented digitally as submitted. For a list of all available file types and 
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Supplemental Digital Content 1.wmv 
SDC File Requirements 
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Appendix I- Permission for Questionnaires 
RE: Order Form for Department of Symptom Research Assessment Tools 
symptomresearch [symptomresearch@mdanderson.org] 
Sent: 29 August 2014 15:55 
To: Doughty Caitriona (NHS FIFE)  
Cc: symptomresearch [symptomresearch@mdanderson.org]  
Attachments: 





I have attached the BPI as you requested. Please note that: 
 
• Your use of the BPI is limited only to the study specified. To use the BPI in 
additional studies, you must reapply online 
at  www.mdanderson.org/departments/prg > Symptom Assessment Tools > The Brief 
Pain Inventory (BPI). 
•         You are permitted to reproduce the copy of the BPI that is included 
with this e-mail. However, you must not remove the copyright notice. 
• The BPI may not be modified in any way or translated into another language 
without the express written consent of the copyright holder; Charles S. 
Cleeland, PhD. Failure to comply may result in legal action. Permission to alter 
or translate the instrument may be obtained by contacting me at 
symptomresearch@mdanderson.org or by mail. 
                 





Mary Samad  
















Caitríona Doughty (Principal Investigator) 
 











Research Question 5 
  
Study Sample 6 
Inclusion and Exclusion Criteria 7 
  
Consent process 6 




Data Collection 7 
  
Analysis plan 10 
  













*Caitríona Doughty (Protocol author) 
  Trainee Clinical Psychologist 
  Psychology Department 
  Lynebank Hospital 
  Halbeath Rd 
  DUNFERMLINE 
  KY11 4UW 
 

















Dr Paul G. Morris  










School of Health in Social Science 





0131 651 3956 
p.g.morris@ed.ac.uk 
 
School of Health in Social Science 









List of abbreviations 
Scottish Intercollegiate Guidelines Network- SIGN; American College of Rheumatology- ACR; National 
Health Service- NHS; Self-Compassion Scale- SCS; Rosenberg Self-Esteem Scale- RSES; Brief Pain Inventory 




Chronic pain has been defined by Scottish Intercollegiate Guidelines Network (SIGN 136, 2013) as 
experiencing pain for at least 3 months that does not resolve with treatment. Approximately 20% of the 
adult European population have chronic pain (Breivik et al., 2006). Its management in the community 
remains generally unsatisfactory (van Hecke, Torrance & Smith, 2013). A specific chronic pain condition is 
fibromyalgia, which is diagnosed when an individual presents with widespread soft tissue pain (11 out of 
18 paired tender points) lasting at least three months (Wolfe et al., 1990). Fibromyalgia is estimated to 
affect approximately 2-5% in Western Europe. Although fibromyalgia is the most common chronic 
widespread pain condition, it is often under diagnosed (Perrot, 2008). New criteria released by American 
College of Rheumatology (ACR, 2010) has proposed that focusing on the severity of characteristic 





It is now widely accepted that psychological factors influence the relationship between chronic pain and 
outcomes such as disability and distress (Turk et al., 2008). Therefore, it may be beneficial in terms of 
managing fibromyalgia and other chronic pain conditions to explore possible psychosocial factors that 
contribute to the development of psychological distress in these conditions.  
The association between pain and mental health symptoms in fibromyalgia were reported to be 
significantly higher than those in other chronic pain conditions (Gormsen et al., 2010; Taylor, Jason, & 
Jahn, 2003; Branco et al, 2010). It has been suggested that different mechanisms may be responsible for 
the development of mood disorders in fibromyalgia compared to other chronic pain conditions.  
In particular, self-esteem has been linked to psychological adjustment in various chronic diseases (Chong 
et al, 2009), and how self-esteem is suspected to be a vulnerability factor in fibromyalgia (Johnson et al., 
1997; Michielsen et al., 2006). Previous literature suggests that low self-esteem causes more negative 
affect for chronic disease patients than healthy populations (Bisschop et al., 2004). As self-esteem can be 
an important coping resource, one of the concerns raised by the combination of low self-esteem and 
chronic illness is an increased difficulty in preventing the negative affect from developing into a more 
severe case of depression. Research demonstrated that patients with chronic pain who had lower self-
esteem reported more negative affect, less positive affect and greater symptom severity than individuals 
with higher self-esteem (Juth, Smyth, Santuzzi, 2008). 
 
Despite the benefits of self-esteem, it has been suggested that high self-esteem is related to a number of 
negative outcomes including distortions in self-knowledge and increased aggression (Baumeister et al, 
2003; Croker & Park, 2004). Reasons for this may be that self-esteem relies on meeting standards and 
favourable comparison with others (Neff, 2009). For this reason, research has started to focus on the 
construct of self-compassion which has been defined as the ability to be aware and open about one’s 
flaws, while still being kind towards oneself.   
 
Research on self-compassion is in its early stages, they have found that self-compassion is a significant 
predictor of increased psychological adjustment in people with chronic medical conditions (Wren, Somers, 
& Wright, 2011). Studies have also found that self-compassion correlates negatively with depression and 
anxiety (MacBeth & Gumley, 2012). It must be noted that much of the research on self-compassion has 
been conducted in non-clinical samples. Overall the literature appears to support the claim that self-
compassion benefits people, especially when they experience failures or short comings. Research suggests 




the ‘active’ components (Gilbert et al., 2011; van Dam et al., 2011). This study aims to investigate how 
self-compassion and self-esteem relate to pain outcomes in a chronic pain population, while also 
comparing their relative importance as mediators between pain intensity and outcomes of distress, 
disability and quality of life. It also aims to examine participants with fibromyalgia as a subgroup to 
investigate if there are differences within this population in relation to self-compassion and self-esteem 
as this group has been identified as having significantly high levels of distress and impaired functioning 
compared with other chronic pain patient groups (Gormsen, Rosenberg, Bach, & Jensen, 2010). 
  
Research Question 
Does self-compassion and self-esteem mediate between pain intensity and distress, functioning and 
quality of life? 
 




How does self-compassion and self-esteem relate to pain outcomes in a fibromyalgia subgroup compared 
to the overall chronic pain-group? 
 
Study Sample 
Individuals will be recruited through NHS Fife Pain Management Service, NHS Fife Rheumatic Diseases 
Unit and chronic pain support groups. All documents will each be marked with a unique participant 
number which will not identify the participant personally, ensuring their anonymity. 
 
Patient Inclusion and Exclusion criteria: 
Inclusion 
* Must be at least 18 years of age 
* Able to speak, read and write fluently in English 







*Individual is suffering from malignant or terminal condition such as cancer.  
*Individual has any of the below  
-Intellectual impairment (e.g. Learning Disability, Alzheimers' Disease, Brain Injury) 
-Severe mental illness 
-Primary alcohol misuse  
-Substance misuse 
 
Number of participants 
Given that no previous study has investigated the relationship between these variables in a chronic pain 
sample, the projected effect size for the current study has been conservatively estimated at a moderate 
level of r²= 0.15. Assuming a medium-size relationship between the predictors and the outcomes, α=.05 
and β=.20, the formula N≥50 +8m (where m is the number of predictors) can be used for testing the 
regression (Tabachnick & Fidell, 2007).  
 
After calculating a G*power analysis, it was indicated that the minimum number of participants required 
for this study is 80. In order to carry out the appropriate statistics for this study with sufficient power, it 
is estimated that the required sample number is at least 120 participants. 
 
Previous research has indicated that the response rate of postal survey studies among people with chronic 
pain range between 43-50% (Gunn et al., 2012). Given that the principal researcher aims to access up to 
3 potential sources of recruitment, it is possible that at least 480 questionnaires could be circulated, which 








Participants will be recruited from NHS Fife Pain Management Service and the NHS Fife Rheumatoid 
Disease Unit. This will be a single site study in that participants will only be recruited the NHS Fife area. It 
is anticipated that the majority of participants will be identified by NHS Fife clinical staff (Clinical 
Psychology, Nurse Specialists) through their clinical role with participants. Clinicians will be asked to 
approach any patients they believe fulfil the inclusion/exclusion criteria and to provide them with the 
participant information and consent sheet. Potential participants will not be identified by any personal or 
clinical information. 
Consent will be implied if the individual completes the questionnaires and posts them back to the address 
on the pre-paid envelope 
 
Participant Withdrawal 
The information provided by the participant for the research study will not be identifiable. Therefore, it 
will not be possible to remove their responses from the study after they have posted them back to the 
researcher. This will be made explicitly clear to the potential participants. 
 
Procedure 
Taking part in the study involves completing a number of questionnaires, which should take approximately 
thirty minutes to complete. The participant will also be asked to provide some very basic details e.g. 
gender, age, type of diagnosis which will not identify them personally. If they agree to take part in the 
study, they will be asked to post them back using the pre-paid envelope included.  
 
Data collection 
The study is a cross-sectional design. Attendees at the Fife Pain Management Service (NHS), the 
Rheumatic Disease Unit (NHS) and a voluntary sector chronic pain support groups (not affiliated with the 
NHS) will be recruited. They will be given a questionnaire pack that contains information sheets, a pre-
paid stamped-addressed envelope and six validated questionnaires of pain, self-compassion, self-esteem, 





Permission has been granted by the primary authors for use of all of the questionnaires.  
 
Self-Compassion Scale (SCS; Neff, 2003) is a 26 item scale that assesses levels of self-compassion. There 
are three factors of positive self-compassion: self-kindness, common humanity and mindfulness and three 
factors that focus on a lack of self-compassion and negative self-evaluation: self-judgement, isolation and 
over-identification. Participants indicate how often they engage in these ways of self-relating on a Likert 
scale 1-5. The scale has good reliability with Cronbach’s alpha ranging from .72 to .83 (van Dam, Sheppard, 
Forsyth, & Earleywine, 2011). 
 
Rosenberg Self Esteem Scale (RSES; Rosenberg, 1965) measures a global feeling of self-worth or self-
acceptance. It is rated on a 4 point scale from 1, strongly agree to 4, strongly disagree. The ten statements 
are designed equally to be positive and negative. The total score ranges from 0 to 30. The scale has good 
reliability with a Cronbach’s alpha of 0.89 (Michielsen, van Houdenhove, Leirs, Vandenbrock, & Onghena, 
2006). 
 
Brief Pain Inventory Short Form (BPI-SF; Cleeland, 1991) contains a total of 15 items and assesses for the 
presence of pain, pain intensity and functional interference from pain. It also catalogues the types of pain 
medications being used; the percentage of pain relief obtained from medications and assesses the 
distribution of pain via a body map. The BPI-SF is widely used in clinical trials for pain and is one of the 
instruments recommended by the initiative on methods measurement and pain assessment in clinical 
trials group (Dwarkin et al., 2005). Internal consistency for the Pain Severity Score and for the Interference 
scale has been reported as ranging from 0.85 and 0.88 respectively (jensen et al., 2004). Construct validity 
of the BPI has been supported for the generic assessment of pain as well as specifically for low back pain 
and rheumatoid arthritis (Keller at al., 2004). 
Pain Disability Questionnaire (PDI; Anagnostis, Gatchel, & Mayer, 2004) incorporates a disability-related 
psychosocial component in addition to a physical functioning component related to pain. It yields a total 
functioning disability score ranging from 0 (optimal function) to 150 (total disability), using 11 point Likert 
scale (Gatchel et al., 2006). The PDQ has good reliability with a Cronbach’s alpha of .96. The construct 
related validity of the PDQ was found to be excellent as it correlated well to both the MVAS (0.65-0.81) 





Quality of Life Scale (QOLS; Burckhardt, Woods, Schultz, & Ziebarth, 2003) is a 16 item questionnaire that 
includes various aspects of life such as physical and material well-being, relationships with other people, 
social, community and civic activities, personal development and fulfilment, recreation and 
independence. Each item was scored 0-7 and the total score ranges 16-112. A higher total score shows a 
higher QOL. This scale has shown good internal consistency (α = 0.88), validity and test-retest reliability 
(Pedro et al, 2014). 
 
The Hospital Anxiety and Depression Scale (HADS; Zigmond and Snaith, 1983) is widely used for 
measuring anxiety and depression in clinical populations with physical illness. It contains 14 items and 
gives an overall measure of emotional distress as well as depression and anxiety subscale scores. It has 
shown good internal consistency (α = 0.90-0.93), validity and test-retest reliability (Moorey et al., 1991; 
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Preliminary analyses will be performed to check for missing data, normality and adequacy for 
mediation analysis.  A set of bivariate Pearson’s correlation analyses will explore the relations 
between the proposed mediators of pain and pain outcomes (distress, function and quality of 
life). Of additional interest will be to use multilpe regression to investigate the extent that the 
subscales of the SCS make individual contributions to predictive validity between pain and pain 
outcomes. 
Multiple mediational analysis using the bootstrapping approach as described by Preacher and 
Hayes (2008) and Hayes (2009), will be used to investigate the relative importance that self-
compassion and self-esteem have in the mediation of the relation between pain experiences 
(intensity) and pain outcomes (physical and emotional). To evaluate the magnitude of indirect 
effects, the product of co-efficients approach (Bishop, Fienberg, & Holland, 2008) will be used to 
calculate standard errors of the indirect effects.  
To answer the second question of the study, a series of t-tests will be used to detect differences 
between the Chronic Pain and the Fibromyalgia. 
Data Storage 
All data will be stored in a manner consistent with NHS Fife guidance and policy on confidentiality 
and IT security, and in keeping with data protection legislation. Any of the data removed from 
NHS systems (e.g. for academic project work) will already be fully anonymised therefore, 
patient’s anonymity will be preserved.  
 
Publishing Outcomes 
A report of the findings will be provided to Edinburgh University, the NHS Fife Psychology 
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Appendix L- Participant Information Sheet 
 
 
            
 
 
The relationship between self-compassion, self-esteem and pain in a chronic pain 
population 
 
We would like to invite you to take part in our research study. Before you decide, we 
would like you to understand why the research is being done and what it would involve 
for you. If you have any questions about this study not answered in this information 
sheet, you can contact the researcher, Caitríona Doughty.  
What is the purpose of the study?  
The purpose of the study is to improve understanding of the psychological factors (e.g. 
self-compassion and self-esteem) that contribute to the development of psychological 
distress and disability in chronic pain conditions. Clinical psychologists conduct research 
to contribute to the evidence about factors affecting mental health, in order to improve 
therapeutic approaches such as talking therapies. This study is being conducted as part 
fulfilment of the researcher’s academic requirements of the Clinical Psychology 
Doctorate at University of Edinburgh. No one is being paid for your participation in this 
study. 
Why have I been invited?  
You have been contacted because you are an individual experiencing chronic pain for 
over 3 months, who has been attending any of the following service: NHS Fife Pain 
Management Service, NHS Fife Rheumatic Diseases Unit, Chronic Pain Self Management 
Group in Fife, NHS Lothian Pain Management Programme or NHS Lothian Rheumatology. 




No, you do not have to take part and you do not have to provide a reason. Your decision 
will not affect the standard of care or support you receive. You will be asked by a heath 
care provider or group facilitator if you would like a questionnaire pack for this study. If 
you agree to this, you can then take this home with you and decide whether you would 
like to participate. This study will be accepting response questionnaires from February 
2015 to February 2016. If you complete and return the attached questionnaires, this 
will be taken as your consent to participate. Written consent is not being gathered in 
this study in order to maintain anonymity.  
What am I being asked to do?  
Taking part in this research involves completing a number of questionnaires, which 
should take approximately 35 minutes to complete. You will also be asked to provide 
some very basic details, which will not identify you personally in any way e.g. gender. If 
you agree to take part in this study you are asked to post them back using the pre-paid 
envelope included. This will be the only time information about you, or from you, will 
be required for this study and it will be the end of your participation in the study.  
 
What are the possible disadvantages and risks of taking part?  
The risks or disadvantages identified are minimal when taking part in this study. 
Completion of the questionnaires may be inconvenient and you may find some of the 
questions upsetting. You can stop completing the questionnaires at any time. You should 
speak to your GP if your distress continues. Listed below are a number of resources that 
you can access if you feel distressed. Included in this pack is a leaflet providing contact 
details for a confidential helpline service known as Breathing Space. 
 
Moodcafe- The Well-being Website 





Pain Association Scotland- Self Management for Chronic Pain 
Contact telephone number: 0800 783 6059  
 
What are the possible benefits of taking part? 
While there are no direct benefits to taking part in this study, you may enjoy contributing to 
research that is intended to improve future patient care by providing a broader understanding 
of the factors that influence pain outcomes in a chronic pain population. 
What if there is a problem?  
If you have a concern or complaint about any aspect of this study, you should contact the 
researcher who will do her best to answer your questions (Caitríona Doughty, 01383 
565402). If you would like to speak to an independent adviser who can answer questions 
about the study but is not directly involved in running the research you can contact - Tara 
Graham (Research & Service Development Psychologist), Department of Clinical 
Psychology Stratheden Hospital, Cupar, KY15 5RR. (01334 696336).  
If you remain unhappy and wish to complain formally, you can contact Dr Katherine 
Cheshire, Head of Clinical Psychology Department, NHS Fife (01383 565403), or Paul 
Morris, Academic Tutor for the study (0131 6513956). You may also follow the NHS 
complaints route by contacting the Patient Relations Department office, Room 104, 
Hayfield House, Hayfield Road, Kirkcaldy, KY2 5AH, (01592 648153) or email 
patientrelations.fife@nhs.net. 
What will happen if I don’t want to carry on with the study?  
The information you provide for the research study will not identify you. Therefore, once 
you have returned the questionnaires it will not be possible to remove your responses 
from the study should you change your mind.  




Yes. We will follow ethical and legal practice and all information about you will be 
handled in confidence. Information you provide for this study will not contain any 
personally identifiable information and therefore your participation will be confidential.  
What will happen to the results of the research study? 
A report of the findings will be provided to Edinburgh University, the NHS Fife 
Psychology Department and submitted for publication in a peer reviewed journal. If you 
require a copy of the report, please contact the researcher. Participants will not be 
identified in any way. 
Who has reviewed the study? 
The South East Scotland Research Ethics Committee 01, which has responsibility for 
scrutinising all proposals for medical research on humans in Tayside, has examined the 

















Appendix M- Demographic Information Sheet 
                                                                                                                                                   




Please answer the following questions 
Recruitment site 
(researcher to complete prior to 








Please list any 
diagnosis you have 
been given in relation 







Was this diagnosis 
provided by your GP 
YES                               NO    
Other, please specify  
 
 
 
 
 
Thank you. 
